association	dataset	threshold value	standardized value
CHP212	CCLE Cell Line Gene CNV Profiles	-1.0	-2.02667
PC(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PMC11982601-IMM-175-84-s005.xlsx-Fig5D_LPS-Innate_IRF6	Rummagene Transcription Factor Associations 2026	1.0	null
BRD-K15502712	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.09626
BRD-A25184723	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.75132
PE(22:2(13Z,16Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K13619800	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.52977
PC(o-16:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K18178356	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.14038
PE(24:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-24:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Prostate adenocarcinoma_PRAD_TCGA-KK-A8IG-01A-11R-A36G-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Acute Myeloid Leukemia_LAML_TCGA-AB-2872-03A-01T-0735-13	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Smc5-Smc6 complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	1.427
PMC7880379-aging-13-202285-s003.xlsx-DElncRNA_target-FEZF1_FEZF1	Rummagene Transcription Factor Associations 2026	1.0	null
PE(18:1(9Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
phosphatidylglycerol metabolic process	GO Biological Process Annotations 2025	1.0	null
BRD-K86911380	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.51139
PC(14:1(9Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:D07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.1275
CRCGN014_HEPG2_24H:H09	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.256
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:G07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.53776
RCM-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.25213
Perturb_3836_KO_ING3_SRP304782	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	9.47054
PC(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
Papillary renal cell carcinoma cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.615
BRD-A71833059	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.31469
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
H3K4me3_testis_mm9_1	ENCODE Histone Modification Site Profiles	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.WT.HP_24H:K18	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.56618
GSE155162,GSE155169_1_v_2_buparlisib_human	RummaGEO Drug Perturbation Signatures	1.0	null
COLO205	DepMap CRISPR Gene Dependency	1.0	2.41788
dorsal part of PcP	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.03577
SARS-CoV MA15_Day1-PFU-10^5_None_GSE50000	GEO Signatures of Differentially Expressed Genes for Viral Infections	1.0	1.80956
PC(18:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
epididymis	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.429165
GSE104022_3_v_0_tamoxifen_mouse	RummaGEO Drug Perturbation Signatures	1.0	null
CRCGN014_HEPG2_24H:N09	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.38255
PE(18:1(11Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
Human - Tonsil - L2 - VEGFA+	HuBMAP Azimuth Cell Type Annotations	1.0	null
IMR-32	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-2.45763
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.WT.HP_24H:P03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.47215
PE(20:4(8Z,11Z,14Z,17Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K05090634	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.46983
PC(18:2(9Z,12Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PMC6775191__F8	PFOCR Pathway Figure Associations 2024	1.0	null
PC(15:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
TCF7L1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.05123
PC(16:1(9Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A_48H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.55405
CRCGN015_HEPG2_48H:L02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.95312
BRD-K90230495	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.09367
BRD-K28195874	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.05776
CRCGN009_HEPG2_24H:O03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.82196
PE(20:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
H3K27me3_heart_mm9_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PE(20:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
KLF8	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.9518
CRCGN011_HEPG2_24H:O01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.5564
PE(18:3(9Z,12Z,15Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
NANOG-16518401-CHIP-PET-MESCS-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
Vascular smooth muscle contraction	KEGG Pathways 2026	1.0	null
PC(20:3(8Z,11Z,14Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
r7 basal plate	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.21422
hsa-miR-4649-3p	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.965816
PLCG1	Hub Proteins Protein-Protein Interactions	1.0	null
PE(18:3(9Z,12Z,15Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PMC11167905-10194_2024_1805_MOESM1_ESM.xlsx-S6-Table_S6_MR_results_of_brain_eQTLs_and_migraine_NR3C2	Rummagene Transcription Factor Associations 2026	1.0	null
PC(22:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
ETS2	MotifMap Predicted Transcription Factor Targets	1.0	null
cellular_component	GO Cellular Component Annotations 2015	1.0	null
catalytic activity	GO Molecular Function Annotations 2015	1.0	null
PE(16:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K96945247	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.05394
H4K20me1_T-cell acute lymphoblastic leukemia_hg19_1	ENCODE Histone Modification Site Profiles	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-HT-A5RC-01A-11R-A28M-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
LB1047-RCC	GDSC Cell Line Gene Expression Profiles	-1.0	-2.01517
PC(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
cell type cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.041941
PE(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
IWS1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.87039
PC(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Posterolateral visual area, layer 5	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.14724
CRCGN017_MCF10A.WT.HP_24H:E04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.51854
BRD-K86893953	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.84858
PC(20:4(8Z,11Z,14Z,17Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K09468701	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.03818
PC(22:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-FG-A6J3-01A-11R-A31N-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K96641838	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.35202
PE(18:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
EKVX	BioGPS Cell Line Gene Expression Profiles	-1.0	-0.917923
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
primary visual cortex (striate cortex, area V1/17)_36 yrs_M_12302	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.75033
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
RAJI	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.37498
PC(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
GATA6-21074721-CACO-2-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(20:3(8Z,11Z,14Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K85527716	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.13879
PC(18:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
SW 403	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.03978
Zic2	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	32.5365
PC(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
SLR26	CCLE Cell Line Gene Expression Profiles	1.0	1.60673
PC(20:3(8Z,11Z,14Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-3173-3p	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.965816
Mafg	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	29.7917
PC(22:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-16:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
HN	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.03978
PC(15:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
Perturb_16475_KO_Irf6_SRP173803	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	-1.0	-9.73818
CRCGN013_HEPG2_24H:C20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.86945
PE(15:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K96243955	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.20057
GRANTA519	CCLE Cell Line Gene CNV Profiles	-1.0	-1.41625
PC(18:4(6Z,9Z,12Z,15Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
KLE	CCLE Cell Line Gene CNV Profiles	1.0	1.65903
GA10	CCLE Cell Line Gene Expression Profiles	1.0	1.86573
CRCGN009_HEPG2_24H:F03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.06915
Paraflocculus, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.81338
r7 part of the basointermediate reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.678
PMC7783757__F7	PFOCR Pathway Figure Associations 2024	1.0	null
PC(P-18:1(11Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Immune system disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.465
PRKDC	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.54676
PC(20:1(11Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
TWIST1_01_253	KnockTF Gene Expression Profiles with Transcription Factor Perturbations	1.0	4.21885
CDX2-21074721-CACO-2-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
ELF3-26769127-CHIP-SEQ-PDAC-CELL-LINE-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(20:3(5Z,8Z,11Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Piriform-amygdalar area, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.06234
NCIH1385	CCLE Cell Line Gene CNV Profiles	-1.0	-2.44461
BRD-K86077185	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.91814
PMC10794847-mmc5.xlsx-PIAS1_KD_up-Table_S4_Differentially_expressed_genes_with_PIAS1_knockdown_in_the_progenitors_state_Related_to_Figure_5_AR	Rummagene Transcription Factor Associations 2026	1.0	null
subbrachial nucleus, caudal part	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.57362
NCI-H1944	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.928367
TEAD1	JASPAR Predicted Transcription Factor Targets	1.0	null
posteroventral (inferior) parietal cortex_21 pcw_F_12365	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.889501
PE(20:4(5Z,8Z,11Z,14Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K18601936	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.15407
integumentary system disease	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.049477
PE(22:1(13Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
NACC1-18358816-MESCS-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PE(14:1(9Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4283	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
PE(20:1(11Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
GSE143782_3_v_4_calcitriol_human	RummaGEO Drug Perturbation Signatures	1.0	null
PE(15:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
Autoimmune disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.501
PC(14:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K01793276	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.48998
PC(20:3(5Z,8Z,11Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-98	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.40969
SW684	COSMIC Cell Line Gene Mutation Profiles	1.0	null
EZH2	ENCODE Transcription Factor Targets	1.0	null
GSE169356_2_v_4_ivermectin_human	RummaGEO Drug Perturbation Signatures	-1.0	null
CRCGN015_HEPG2_48H:C23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.396
PE(20:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:J16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.74739
PC(22:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN009_HEPG2_24H:F19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.41415
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
mainolfactoryepithelium.MOE.	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	-1.0	-1.04108
CRCGN009_HEPG2_24H:H15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.56075
PE(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
MITF	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	19.6646
PE(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:1(11Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K52047843	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.32447
CRCGN014_HEPG2_24H:B08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.7198
BRD-K11095218	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.53552
BRD-K92700781	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.08789
BRD-K24385654	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.28031
plasma membrane	LOCATE Curated Protein Localization Annotations	1.0	null
PC(P-18:1(9Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
496100640_PCx_no dementia_no TBI_95-99_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	2.48523
abnormal eye morphology	MGI Mouse Phenotype Associations 2023	1.0	null
CRCGN009_HEPG2_24H:H02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.77239
PE(20:3(5Z,8Z,11Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
r9 part of ventral parvicellular reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.15205
phosphatidylglycerol metabolic process	GO Biological Process Annotations 2023	1.0	null
Connective tissue disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.492
PC(20:2(11Z,14Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
GSE174701_1_v_2_maml3_human	RummaGEO Gene Perturbation Signatures	1.0	null
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-MA-AA41-01A-11R-A38B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CDX2-22108803-LS180-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(P-16:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
cSARS Bat SRBD_30Hour_None_GSE37827	GEO Signatures of Differentially Expressed Genes for Viral Infections	1.0	1.81185
PE(18:1(11Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
Kidney Chromophobe_KICH_TCGA-KN-8432-11A-01R-2315-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(20:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GSE130217_5_v_3_sesn2_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
intermediate stratum of r5Ve	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.12851
PC(20:4(8Z,11Z,14Z,17Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
intracellular part	GO Cellular Component Annotations 2015	1.0	null
BRD-K36997940	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.1366
CRCGN017_MCF10A.TP53.M_24H:O21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.81188
Arteriosclerosis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.309
PE(22:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Primary immunodeficiency disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.516
PE(18:3(9Z,12Z,15Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
t70-white-adipose_consensus	MoTrPAC Rat Endurance Exercise Training	1.0	1.52642
phosphatidic acid metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(16:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
Skin Cutaneous Melanoma_SKCM_TCGA-EB-A4IQ-01A-12R-A266-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:1(9Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CTCF_thymus_mm9_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
intermediate stratum of m2Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.26709
PC(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
ammonium ion metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(22:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
regulation of T cell proliferation	GO Biological Process Annotations 2023	1.0	null
CRCGN009_HEPG2_24H:L13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.94145
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
periventricular stratum of r4Ve	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.12176
posterior (caudal) superior temporal cortex (area 22c)_19 pcw_F_12885	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.01866
PC(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
testis	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.174425
PC(20:2(11Z,14Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
KARPAS620	CCLE Cell Line Gene Expression Profiles	1.0	1.63272
hsa-miR-103a	TargetScan Predicted Conserved microRNA Targets	1.0	0.598666
PE(18:4(6Z,9Z,12Z,15Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
Skin disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.656
cellular_component	COMPARTMENTS Text-mining Protein Localization Evidence Scores	1.0	0.040046
Kidney renal clear cell carcinoma_KIRC_TCGA-CJ-4642-01B-01R-1305-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
gland	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
CRCGN014_HEPG2_24H:L18	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.18696
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
COR-L279	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.862994
Head and Neck squamous cell carcinoma_HNSC_TCGA-UF-A7JJ-01A-11R-A34R-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
small testis	MGI Mouse Phenotype Associations 2023	1.0	null
PC(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:M17	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.70884
arachidonic acid metabolism	KEGG Pathways	1.0	null
organic substance biosynthetic process	GO Biological Process Annotations 2015	1.0	null
PE(22:2(13Z,16Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
amygdaloid complex_17 pcw_F_12880	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.39954
PC(18:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K77820762	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.097
PE(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PMC2742785__F8	PFOCR Pathway Figure Associations 2023	1.0	null
PC(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K87920761	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.73347
PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Skin papilloma	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.041
Merocrine gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.526
PYCR1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.65923
CRCGN013_HEPG2_24H:B07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.50406
PC(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GSE160817_3_v_8_slamf6_human	RummaGEO Gene Perturbation Signatures	1.0	null
PE(20:3(5Z,8Z,11Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
COLO668	CCLE Cell Line Gene CNV Profiles	1.0	2.17028
PC(20:4(8Z,11Z,14Z,17Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K52154207	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.4581
PC(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-20:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-MP-A4SY-01A-21R-A24X-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
HCC515	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.914318
HT1197	CCLE Cell Line Gene CNV Profiles	1.0	1.35022
Palmitic acid	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
DIFI	DepMap CRISPR Gene Dependency	1.0	2.9689
PC(P-16:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-22:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PMC9942993-pone.0281645.s002.xlsx-AR-as_adaptive-ENSEMBL_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PC(14:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
GSE88819_0_v_4_tug1_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
KARPAS422	DepMap CRISPR Gene Dependency	1.0	4.231
PE(18:4(6Z,9Z,12Z,15Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN011_HEPG2_24H:J13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.8546
PC(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CFPAC-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.11844
Brain Lower Grade Glioma_LGG_TCGA-VM-A8C9-01A-11R-A36H-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(20:2(11Z,14Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
SOX4	MotifMap Predicted Transcription Factor Targets	1.0	null
PE(18:1(11Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
vascular system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.074259
hsa-miR-3907	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.0155
Calcitonin family receptor complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.695
CRCGN013_HEPG2_24H:O02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.94316
PC(14:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H146	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.976666
PC(20:3(5Z,8Z,11Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-20:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PMC5894239-12864_2018_4591_MOESM9_ESM.xlsx-ST12_mir_downregulated-Ensembl_ID_KLF6	Rummagene Transcription Factor Associations 2026	1.0	null
PC(22:2(13Z,16Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K43611837	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.26172
orbital frontal cortex_3 yrs_M_12980	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.72816
PE(18:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN013_HEPG2_24H:O06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.36401
PE(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Overnutrition	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.053
PE(24:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
FOXA1-27270436-VCAP-HUMAN-PROSTATE-CARCINOMA	ChEA Transcription Factor Targets 2022	1.0	null
GSE42805,GSE42811_1_v_3_cocaine_mouse	RummaGEO Drug Perturbation Signatures	1.0	null
PC(14:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
whole body	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
BRD-K83300227	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.00955
amygdaloid complex_2 yrs_F_12979	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	2.94431
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:H05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.88216
striatum_4 yrs_M_12298	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.13654
PC(24:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
inferolateral temporal cortex (area TEv, area 20)_21 yrs_F_13057	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.94749
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
regulation of T cell proliferation	GO Biological Process Annotations 2025	1.0	null
CRCGN009_HEPG2_24H:O19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.5692
cytoplasm	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.237908
posteroventral (inferior) parietal cortex_19 pcw_F_12885	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.03135
PE(18:2(9Z,12Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
Venom apparatus	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.999
BRD-K86855109	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.43788
PE(20:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K65774385	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.15963
QGP1	CCLE Cell Line Gene Expression Profiles	-1.0	-1.80136
viscus	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A3MF-01A-12R-A21D-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(22:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PMC11551338-pnas.2411189121.sd01.xlsx-AHR-Unnamed_0_AHR	Rummagene Transcription Factor Associations 2026	1.0	null
PE(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Epididymal epithelium	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.055
BRD-K89687419	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.88929
Lung squamous cell carcinoma_LUSC_TCGA-56-8622-01A-11R-2403-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
COR-L88	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.951468
PE(20:3(5Z,8Z,11Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
A-61603	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.06056
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-C5-A7CH-01A-11R-A33Z-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PMC2742785__F8	PFOCR Pathway Figure Associations 2024	1.0	null
BRD-K41603100	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.45768
HELA	BioGPS Cell Line Gene Expression Profiles	-1.0	-1.08445
Rumen	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.801
PE(22:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
NHEK cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.966
CRCGN015_MCF10A.WT.HP_24H:H08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.25306
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:K06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.09354
DB	CCLE Cell Line Gene Expression Profiles	1.0	1.5065
GSE216043_3_v_2_cisplatin_human	RummaGEO Drug Perturbation Signatures	1.0	null
BRD-K14210122	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.00583
PC(18:3(9Z,12Z,15Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
C3A	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.20101
PC(22:1(13Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
496100585_PCx_possible Alzheimer's disease_TBI_100+_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	2.15435
gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.055299
PC(20:4(5Z,8Z,11Z,14Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
r4 part of parvocellular medial vestibular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.12176
PE(18:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
AKT1_knockout_213_GSE39699	GEO Signatures of Differentially Expressed Genes for Kinase Perturbations	-1.0	-2.04618
PE(22:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
phospholipases	HumanCyc Pathways	1.0	null
Motor trigeminal nucleus	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.714
CRCGN015_MCF10A.TP53.M_24H:G06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.09786
PE(22:1(13Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K52261313	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.45077
PE(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
HLF	DepMap CRISPR Gene Dependency	1.0	2.61922
Bladder Urothelial Carcinoma_BLCA_TCGA-UY-A78O-01A-12R-A33J-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Cerebellum	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.62599
PC(o-18:1(11Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
liminal part of alar p1	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.08356
PC(20:4(5Z,8Z,11Z,14Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-3142	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.809003
PE(18:4(6Z,9Z,12Z,15Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
RT4	CCLE Cell Line Gene CNV Profiles	-1.0	-1.44744
BRD-K45576113	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.74113
BRD-A22089150	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.65865
Crus 2, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.55051
PC(o-18:1(9Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:O04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.51997
PE(18:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
HCC630	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.10237
PC(16:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K96280720	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.08766
PFKL_OE_GDS3353_76_human_B cells in blood	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
BRD-K93615384	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.28663
Heptadecanoyl CoA	HMDB Metabolites of Enzymes	1.0	null
r1 alar plate	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.86795
BRD-K19237647	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.21258
Acute Myeloid Leukemia_LAML_TCGA-AB-2832-03A-01T-0736-13	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
inferolateral temporal cortex (area TEv, area 20)_8 yrs_M_12841	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-0.921526
PC(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
SNU5	CCLE Cell Line Gene CNV Profiles	-1.0	-1.69021
CRCGN012_HEPG2_24H:D08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.60724
organic hydroxy compound metabolic process	GO Biological Process Annotations 2015	1.0	null
RAD21-21589869-MESC-MOUSE	ChEA Transcription Factor Binding Site Profiles	1.0	null
PE(16:1(9Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
19192944-TableS4	GeneSigDB Published Gene Signatures	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PMC9942993-pone.0281645.s002.xlsx-AR-as_all-SYMBOL_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PC(20:1(11Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K48069820	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.50628
hsa-miR-4723-3p	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.965816
PC(20:3(8Z,11Z,14Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN010_HEPG2_24H:O03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.04158
CRCGN017_MCF10A.TP53.M_24H:P19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.08764
PMC9794594-DataSheet_1.xlsx-ST12-Unnamed_6_KLF6	Rummagene Transcription Factor Associations 2026	1.0	null
KLF4_01_339	KnockTF Gene Expression Profiles with Transcription Factor Perturbations	1.0	1.01645
NR4A1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	29.469
BRD-K45495792	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.07461
CRCGN015_HEPG2_48H:P06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.26492
PE(18:3(6Z,9Z,12Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
epidermis	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	1.0	1.23083
ChIP_POU5F1_16518401	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	1.0	null
PC(P-18:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(o-22:3(10Z,13Z,16Z)/22:3(10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE145215_2_v_1_krt13_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PE(18:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:G05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.69098
PC(18:2(9Z,12Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
SOX10	MotifMap Predicted Transcription Factor Targets	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Crus 1, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.10934
PC(o-18:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PRXL2A	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.5807
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-A08759443	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.34262
NACC1	ChEA Transcription Factor Targets	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-D6-A6EK-01A-11R-A31N-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PTOV1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.82067
CAL-148	GDSC Cell Line Gene Expression Profiles	1.0	1.55584
Perturb_14675_KO_RpL13a_SRP090469	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	-1.0	-2.68835
BRD-K85604751	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.01255
PC(P-16:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K57937572	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.94663
NURR1	MotifMap Predicted Transcription Factor Targets	1.0	null
BRD-K72034944	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.15442
CRCGN015_HEPG2_48H:C21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.46093
PC(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:1(9Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
gut	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.113304
BRD-K74688087	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.3031
PC(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN010_HEPG2_24H:D01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.29456
PC(16:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K83751422	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.67209
PC(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
GSE152441,GSE152442_7_v_5_folic acid_human	RummaGEO Drug Perturbation Signatures	1.0	null
PE(22:1(13Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
HES5	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	18.5792
PC(18:2(9Z,12Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
EVSA-T	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.881129
CRCGN009_HEPG2_24H:D05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.18115
male reproductive system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.116444
PE(14:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
lipid metabolic process	GO Biological Process Annotations 2015	1.0	null
PC(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Skin Cutaneous Melanoma_SKCM_TCGA-EB-A550-01A-61R-A27Q-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
cardiovascular system	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
Lobule III	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.27348
PE(18:2(9Z,12Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
TWIST1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	46.0988
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
posterior (caudal) superior temporal cortex (area 22c)_12 pcw_F_13060	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.861229
PC(P-16:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K98505253	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.02088
binding	GO Molecular Function Annotations 2015	1.0	null
PC(18:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
single-organism metabolic process	GO Biological Process Annotations 2015	1.0	null
PC(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
iPS-18 Cells	Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles	1.0	1.25983
glycerolipid biosynthetic process	GO Biological Process Annotations 2015	1.0	null
PE(15:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(O-16:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K23800773	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.03478
496100365_HIP_probable Alzheimer's disease_TBI_84_M	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	4.3908
KURAMOCHI	CCLE Cell Line Gene CNV Profiles	1.0	1.47232
PE(22:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
MACROH2A1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.45983
dorsolateral prefrontal cortex_15 yrs_M_12299	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.844808
PC(15:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K31939603	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.11036
HKA1	DepMap CRISPR Gene Dependency	1.0	3.58018
mantle zone of m2Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.45386
Accessory facial motor nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.26386
hsa-miR-185	TargetScan Predicted Conserved microRNA Targets	1.0	0.075559
hsa-miR-34c-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.921135
PC(16:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PMC7738479-Table_2.XLSX-MARKERS-ADC_markers_specific_for_either_SETDB1-high_or_-low_samples_SETDB1	Rummagene Transcription Factor Associations 2026	1.0	null
PE(20:2(11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
MYF6	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	27.777
subbrachial nucleus, rostral part	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.56178
intermediate stratum of r7BM	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.98101
abnormal eye morphology	IMPC Knockout Mouse Phenotypes	1.0	null
H3K4me1_brain_mm9_1	ENCODE Histone Modification Site Profiles	1.0	null
BRD-K68086276	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.6714
Hair follicle inner root sheath	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.264
PE(24:1(15Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Acute Myeloid Leukemia_LAML_TCGA-AB-2897-03A-01T-0735-13	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:C22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.60581
PC(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K81277520	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.72612
PC(18:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Adrenocortical carcinoma_ACC_TCGA-OR-A5LC-01A-11R-A29S-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(24:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-3155	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
BRD-K77638937	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.37969
PMC3485261-pone.0046600.s008.docx-0-V_SMAD4_Q6_SMAD4	Rummagene Transcription Factor Associations 2026	1.0	null
PC(20:1(11Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GSK3B_knockdown_158_GSE35351	GEO Signatures of Differentially Expressed Genes for Kinase Perturbations	1.0	1.6052
BRD-K31348453	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.06121
PE(24:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-1245b-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.0155
PE(22:1(13Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN008_HEPG2_24H:C21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.51315
macromolecular complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores	1.0	0.040251
Copula pyramidis, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.51747
PC(15:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
GSE161170,GSE161268_1_v_3_med1_human	RummaGEO Gene Perturbation Signatures	1.0	null
inferolateral temporal cortex (area TEv, area 20)_1 yrs_F_12830	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.29612
PE(18:3(9Z,12Z,15Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
intermediate stratum of r5BM	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.03146
BRD-K41192699	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.06817
PE(20:1(11Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
Gfi1b_OE_GDS4302_425_mouse_AMuLV (pro-B Abelson leukemia virus transformed) cell line	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
phosphatidylserine acyl-chain remodeling	GO Biological Process Annotations 2023	1.0	null
BRD-K58245095	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.12244
PC(22:1(13Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-P5-A5F2-01A-11R-A28M-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CRCGN009_HEPG2_24H:C20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.21774
PE(20:4(5Z,8Z,11Z,14Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/dm18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
HCC2218	CCLE Cell Line Gene CNV Profiles	-1.0	-1.7782
PC(22:1(13Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
tonsil	HPA Tissue Gene Expression Profiles	1.0	1.46154
PC(16:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:D03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.11192
PC(18:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
Respiratory system	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
superficial dorsofrontal area	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.17431
CRCGN016_MCF10A.TP53.M_24H:E20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.98235
GFI1B-20887958-HPC-7-MOUSE	ChEA Transcription Factor Binding Site Profiles	1.0	null
GFI1B-20887958-HPC-7-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
Plantar fascial fibromatosis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.551
NEUROG1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	20.0081
phospholipase A2 activity	GO Molecular Function Annotations 2025	1.0	null
PE(20:2(11Z,14Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:N14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.7753
CRCGN015_HEPG2_48H:I10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.19647
SKHEP1	DepMap CRISPR Gene Dependency	1.0	2.86559
PE(22:2(13Z,16Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
P-388D1 cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.207
Dermal papilla	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.665
CRCGN015_HEPG2_48H:P13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.47807
CRCGN016_MCF10A.TP53.M_24H:L10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.92829
BRD-K35108166	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.10419
PC(20:4(8Z,11Z,14Z,17Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Autoimmune disease of musculoskeletal system	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.637
MAX_NB4_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
Skin Cutaneous Melanoma_SKCM_TCGA-EB-A4OZ-01A-12R-A266-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(14:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
cerebellar white matter	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.96914
PE(20:3(8Z,11Z,14Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
LS1034	DepMap CRISPR Gene Dependency	1.0	4.60642
H6PD_KO_GDS3195_602_mouse_Skeletal muscle - Soleus	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
CHP-212	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-2.07453
ZDHHC6	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.11158
PC(16:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-16:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
tunica intima vasorum	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.165852
CRCGN013_HEPG2_24H:G16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.9018
ventrolateral part of alar p1	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.08356
intermediate stratum of r10BI	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.37131
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
cortex of cerebellar vermis	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.29071
BRD-K46126513	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.28812
BRD-K92767663	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.44194
PC(P-16:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-let-7b	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
PE(14:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
Liver hepatocellular carcinoma_LIHC_TCGA-MR-A8JO-01A-12R-A36F-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K56957303	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.12378
PE(24:1(15Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
colon cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.261245
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE180200,GSE180201_15_v_6_qpctl_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
r4 part of reticulotegmental nucleus, shell portion	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.00045
CRCGN011_HEPG2_24H:C20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.6299
PE(18:2(9Z,12Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
glycerolipid metabolic process	GO Biological Process Annotations 2015	1.0	null
BRD-K38381720	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.24772
PC(P-18:1(11Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4644	TargetScan Predicted Conserved microRNA Targets	1.0	0.088999
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
synoviocyte	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.685959
SNRPG	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	-1.0	-3.3201
PE(20:1(11Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
GSE124048,GSE124067_1_v_0_irf6_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
mantle zone of r10BL	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.48167
NR4A2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	23.0283
PC(20:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
Ptf1a	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	73.5102
H3K4me1_limb_mm9_1	ENCODE Histone Modification Site Profiles	1.0	null
PC(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Pancreatic secretion	KEGG Pathways 2026	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE154350_1_v_0_ascl2_human	RummaGEO Gene Perturbation Signatures	1.0	null
CRCGN015_MCF10A.WT.HP_24H:P17	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.27866
LS513	CCLE Cell Line Gene CNV Profiles	-1.0	-1.78986
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
TGIF2LY	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	57.6572
dermatitis	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.304864
GSE145249_1_v_3_ppm1g_human	RummaGEO Gene Perturbation Signatures	1.0	null
PE(24:1(15Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
dorsolateral prefrontal cortex_30 yrs_F_12290	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.03041
SUM44PE	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	-1.0	-0.708513
PE(18:4(6Z,9Z,12Z,15Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
Allergic disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.226
PE(18:3(6Z,9Z,12Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H1793	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.01912
BRD-K21635266	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.1738
Lung adenocarcinoma_LUAD_TCGA-55-7284-01B-11R-2241-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Linoleic acid	MW Enzyme Metabolite Associations	1.0	null
PC(22:2(13Z,16Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:L04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.11279
NCIH209	CCLE Cell Line Gene CNV Profiles	-1.0	-2.22071
CRCGN017_MCF10A.WT.HP_24H:N02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.14095
PC(20:3(5Z,8Z,11Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
LysoPC(24:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K25236390	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.5688
PE(20:4(5Z,8Z,11Z,14Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K90460185	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.81188
PC(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Uterine Carcinosarcoma_UCS_TCGA-N6-A4VC-01A-11R-A28V-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
GSE74528_0_v_1_trex2_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PHF8-20622853-HELA-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PMC11868582-41423_2025_1264_MOESM4_ESM.xlsx-Table_S10-Table_S10_List_of_FICZ-induced_or_FICZ-suppressed_and_OVOL1-dependent_genes_OVOL1	Rummagene Transcription Factor Associations 2026	1.0	null
MM383	DepMap CRISPR Gene Dependency	1.0	2.20045
PE(20:2(11Z,14Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.TP53.M_24H:N16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.72405
FOXC1	JASPAR Predicted Transcription Factor Targets	1.0	null
PC(22:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K71472853	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.3305
GSE180200,GSE180201_12_v_0_qpctl_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
GSE180200,GSE180201_2_v_0_qpctl_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
MZF1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	35.4033
superficial stratum of cerebellar hemisphere	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.02645
PC(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
Atopic dermatitis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.308
PE(20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
HCC202	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.914318
PE(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
GSE216147_0_v_1_rbm20_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
FOXO3	ChEA Transcription Factor Targets	1.0	null
PC(dm18:1(11Z)/dm18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K36716113	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.58262
PC(14:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K69698801	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.20489
PMC10042887-41419_2023_5742_MOESM3_ESM.xlsx-Table_S3-Table_S3_Differently_expressed_genes_in_HOXB3_vs_HOXB3-_aPCA_HOXB3	Rummagene Transcription Factor Associations 2026	1.0	null
PC(22:2(13Z,16Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
NCIH23	DepMap CRISPR Gene Dependency	1.0	2.36789
MCIXC	DepMap CRISPR Gene Dependency	1.0	6.66193
H3K36me3_H1 BMP4 Derived Trophoblast Cultured Cells	Roadmap Epigenomics Histone Modification Site Profiles	1.0	null
PC(15:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K58996625	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.22522
PE(16:1(9Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K98008739	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.71279
POU5F1	ChEA Transcription Factor Targets	1.0	null
GSE253041_1_v_0_ramp1_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
496100436_FWM_no dementia_no TBI_95-99_M	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	2.85419
LysoPC(O-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
GSE74251_2_v_1_decitabine_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(P-18:1(11Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PU.1	MotifMap Predicted Transcription Factor Targets	1.0	null
GSE224547_1_v_0_cftr_human	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(20:3(5Z,8Z,11Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-N417	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.17947
CRCGN014_HEPG2_3H:P03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.1262
PC(18:2(9Z,12Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
Declive (VI)	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.52599
CRCGN011_HEPG2_24H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.60085
Arteriosclerotic cardiovascular disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.317
Companion cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.21
LysoPC(P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H1666	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.25314
FOXA1_T47D_hg19_2	ENCODE Transcription Factor Binding Site Profiles	1.0	null
STAT5-23275557-MAMMARY-EPITHELIUM-MOUSE	ChEA Transcription Factor Binding Site Profiles	1.0	null
PC(o-24:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
glycerophospholipid metabolic process	GO Biological Process Annotations 2015	1.0	null
NCI-H2595	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.11844
cortex of cerebellar hemisphere	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.02563
Phospholipase A2 domain	InterPro Predicted Protein Domain Annotations	1.0	null
PC(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K48501991	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.10996
primary auditory cortex (core)_3 yrs_M_12980	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.06382
PC(P-18:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
MB-49 cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.641
Liver hepatocellular carcinoma_LIHC_TCGA-DD-A1EK-01A-11R-A213-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(14:1(9Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
cellular_component	LOCATE Curated Protein Localization Annotations	1.0	null
CRCGN014_HEPG2_3H:N09	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.34206
cell	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.237908
CRCGN009_HEPG2_24H:O06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.70563
r6 part of gigantocellular reticular area	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.54188
BRD-K68618894	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.00368
tendon sheath	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.460692
PC(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Phospholipase A2, active site	InterPro Predicted Protein Domain Annotations	1.0	null
Inherited metabolic disorder	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.013
ESRRA	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	26.7115
BRD-K28429328	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.60387
PE(20:3(8Z,11Z,14Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Intermediate reticular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.08808
PC(18:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K27909962	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.2772
PC(20:1(11Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
extracellular region part	COMPARTMENTS Text-mining Protein Localization Evidence Scores	1.0	0.043924
BRD-A89947015	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.71944
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
HaCaT cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.968
PE(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
501A	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.929214
increase	GeneRIF Biological Term Annotations	1.0	null
BRD-K28021686	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.17055
PE(24:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
novobiocin-na	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.67063
PE(22:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
hydrolase activity	GO Molecular Function Annotations 2015	1.0	null
PC(P-18:1(11Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PMC9942993-pone.0281645.s002.xlsx-AR-as_all-ENSEMBL_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PE(20:3(8Z,11Z,14Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:A17	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.34059
PC(24:1(15Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
THAP1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	34.4942
Phosphatidylcholine	MW Enzyme Metabolite Associations	1.0	null
496100420_PCx_probable Alzheimer's disease_no TBI_85_M	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	2.76401
PE(14:1(9Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
leydig cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.553683
CRCGN015_HEPG2_48H:G01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	10.0
phospholipase activity	GO Molecular Function Annotations 2015	1.0	null
CRCGN012_HEPG2_24H:G01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.73797
PC(20:1(11Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN009_HEPG2_24H:E21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.55634
PE(18:1(11Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
GSE151829,GSE151831_1_v_8_aire_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
LysoPC(18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
DU-145	COSMIC Cell Line Gene Mutation Profiles	1.0	null
RMG-I	GDSC Cell Line Gene Expression Profiles	1.0	2.17602
mantle zone of r9BI	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.62519
hsa-miR-4306	TargetScan Predicted Conserved microRNA Targets	1.0	0.075559
PE(20:2(11Z,14Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
blood vessel endothelium	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.104269
BRD-K41620124	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.61461
HCC1599	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	-1.0	-1.09858
BRD-K47801291	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.03283
JM1	CCLE Cell Line Gene Expression Profiles	1.0	1.60348
GSE131161_2_v_4_rarres1_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(22:1(13Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K74971765	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.59406
SKMM2	CCLE Cell Line Gene Expression Profiles	1.0	1.47288
GSE164529_0_v_3_tamoxifen_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Copula pyramidis, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.54638
PE(22:5(7Z,10Z,13Z,16Z,19Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-1200	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
Bacterial extracellular vesicle	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.606
Rumen epithelium	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.913
PC(20:1(11Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
DON cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.867
LysoPC(20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Gastrointestinal system disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.05
hsa-miR-4481	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.965816
E2F3_KD_GDS4094_448_mouse_Mammary tumors (Myc-induced)	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	null
RAD21	ChEA Transcription Factor Targets	1.0	null
cerebellar cortex_4 mos_M_12296	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-0.8757
PC(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
internal granular layer of CbHCx	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.0464
Heart	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
JHUEM1	DepMap CRISPR Gene Dependency	1.0	2.14443
BRD-K87595216	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.33317
CRCGN017_MCF10A.TP53.M_24H:N03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.98035
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
cobalt chloride-383	CMAP Signatures of Differentially Expressed Genes for Small Molecules	1.0	null
periventricular stratum of p1B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.86535
PE(15:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
Acute Myeloid Leukemia_LAML_TCGA-AB-2866-03A-01T-0736-13	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
phosphatidylethanolamine acyl-chain remodeling	GO Biological Process Annotations 2023	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A20P-01A-11R-A14Y-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K35717699	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.09559
PE(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
cellular lipid metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(22:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(o-20:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:2(9Z,12Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
CEBPB-20513432-MACROPHAGES-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
BRD-K53617314	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.16225
catabolic process	GO Biological Process Annotations 2015	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.TP53.M_24H:J01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.0085
CRCGN017_MCF10A.TP53.M_24H:N02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.3514
PE(20:3(5Z,8Z,11Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
intermediate stratum of p1Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.2172
BRD-K82145108	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.22884
BRD-K48533326	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.07688
PC(20:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Perturb_10230_KD_FOXC1_SRP068208	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	-2.71476
PC(14:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
IGR1	DepMap CRISPR Gene Dependency	1.0	2.29147
intermediate part of r8B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.02366
PC(24:1(15Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
Kdm1a_KD_GDS5055_274_mouse_3T3-L1 preadipocytes - 24h	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
cation binding	GO Molecular Function Annotations 2015	1.0	null
TGIF2LX	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	59.367
ALDH1A2_KO_GDS4836_290_mouse_anterior embryonic brain	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN009_HEPG2_24H:H01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.2371
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K22071228	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.09843
DJ-1_KD_GDS3750_373_human_SH-SY5Y	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
PE(15:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K74138110	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.46486
STAT3-23295773-U87-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
levallorphan-tartrate	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.28709
PC(P-18:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4268	TargetScan Predicted Conserved microRNA Targets	1.0	0.32519
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:G13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.5537
PC(18:3(9Z,12Z,15Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K21584435	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.00147
PE(18:3(6Z,9Z,12Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
Eccrine sweat gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.526
pancreas	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	1.0	1.07371
lymphocyte	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.057901
BRD-K73127443	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.26844
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE121866_0_v_3_six4_human	RummaGEO Gene Perturbation Signatures	-1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
large intestine cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.05675
MHHES1	CCLE Cell Line Gene Expression Profiles	-1.0	-2.64355
BRD-K40116023	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.18751
PC(o-22:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
GNAI3	Hub Proteins Protein-Protein Interactions	1.0	null
PC(18:1(9Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K45723655	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.79733
BRD-K07589203	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.05061
PC(24:1(15Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.TP53.M_24H:O12	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.78605
PC(20:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN008_HEPG2_24H:D11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.3843
intermediate stratum of r10BL	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.48167
PE(18:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
Uterine Carcinosarcoma_UCS_TCGA-ND-A4W6-01A-11R-A28V-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
LEF1-29337183-MESC-MOUSE-STEM	ChEA Transcription Factor Targets 2022	1.0	null
COV318	CCLE Cell Line Gene CNV Profiles	1.0	1.52662
hsa-miR-296-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.921135
BRD-K11113009	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.28065
BRD-K82814367	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.82909
H3K27me3_liver_mm9_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
Simple lobule, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.83549
TOV21G	CCLE Cell Line Gene Expression Profiles	-1.0	-2.39113
TET2	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.54241
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
r10 basal plate	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.2217
phospholipid metabolic process	GO Biological Process Annotations 2023	1.0	null
BRD-K28247259	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.8922
PC(20:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
calcium ion binding	GO Molecular Function Annotations 2023	1.0	null
CRCGN009_HEPG2_24H:G15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.29722
PE(20:2(11Z,14Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
abnormality of the cardiovascular system	GWASdb SNP-Phenotype Associations	1.0	0.704609
Metabolism of lipids	Reactome Pathways 2024	1.0	null
PC(18:2(9Z,12Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
Heptadecanoic acid	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
posteroventral (inferior) parietal cortex_4 yrs_M_12298	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.97162
PE(22:2(13Z,16Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
SW1783	COSMIC Cell Line Gene Mutation Profiles	1.0	null
Mast cell granule	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.68
BRD-A93436351	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.31029
primary auditory cortex (core)_23 yrs_M_12300	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-0.833284
PE(15:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
organic substance catabolic process	GO Biological Process Annotations 2015	1.0	null
PC(20:3(8Z,11Z,14Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
Venom gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.019
PC(20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
orbital frontal cortex_8 yrs_M_12841	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-0.959961
PMC9170767__F1	PFOCR Pathway Figure Associations 2024	1.0	null
Lung adenocarcinoma_LUAD_TCGA-MP-A4TA-01A-21R-A24X-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
increased grip strength	IMPC Knockout Mouse Phenotypes	1.0	null
posterior (caudal) superior temporal cortex (area 22c)_21 yrs_F_13057	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.35477
PE(20:0/dm18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K77504251	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.16962
PE(20:5(5Z,8Z,11Z,14Z,17Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K78939372	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.37892
PC(22:1(13Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K85271599	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.29496
GSE155305_3_v_0_ifitm3_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
imatinib_homo sapiens_gpl96_gds3048	GEO Signatures of Differentially Expressed Genes for Small Molecules	1.0	null
PC(22:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H847	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.19853
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PMC10794847-mmc2.xlsx-PBRM1_KD_up-Table_S1_Differentially_expressed_genes_with_PBRM1_knockdown_in_the_progenitor_state_Related_to_Figure_1_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PC(20:3(8Z,11Z,14Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:M07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.38366
superficial stratum of PCPD	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.17538
BRD-K33350866	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.08747
tilorone	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.01799
PC(18:1(11Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
H3K4me3_H1 BMP4 Derived Trophoblast Cultured Cells	Roadmap Epigenomics Histone Modification Site Profiles	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-95-A4VN-01A-11R-A262-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K15300571	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.1068
Hair follicle	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.642
PE(16:1(9Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
NCI-H446	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.11976
Human - Tonsil - L2 - FDCSP epithelium	HuBMAP Azimuth Cell Type Annotations	1.0	null
PE(15:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
POU5F1-16518401-MESC-mouse	ChEA Transcription Factor Binding Site Profiles	1.0	null
PC(20:3(5Z,8Z,11Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Cerebellar cortex	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.66422
PC(24:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
5-lipoxygenase complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.729
PC(18:4(6Z,9Z,12Z,15Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
1-Acyl-sn-glycero-3-phosphoethanolamine	MW Enzyme Metabolite Associations	1.0	null
PC(P-18:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
testicular cell line	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.624254
TTC1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	-1.0	-2.35869
Bladder Urothelial Carcinoma_BLCA_TCGA-DK-A6AV-01A-12R-A30C-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
MAFK	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	20.3538
PE(14:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
GSE172458_0_v_1_cisplatin_human	RummaGEO Drug Perturbation Signatures	-1.0	null
lymphoid cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.054705
Skin Cutaneous Melanoma_SKCM_TCGA-EB-A299-01A-21R-A18U-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(14:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K81751970	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.24455
biological_process	GO Biological Process Annotations 2015	1.0	null
PE(18:1(11Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4654	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.921135
PE(18:4(6Z,9Z,12Z,15Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
FOXA1-26743006-CHIP-SEQ-LNCAP-ABL-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PMC9508118-42003_2022_3857_MOESM6_ESM.xlsx-d-Classification_of_camel_SON_basal_genes_-_enzymes_SON	Rummagene Transcription Factor Associations 2026	1.0	null
BRD-K75869095	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.57404
hippocampus (hippocampal formation)_21 yrs_F_13057	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.1464
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Lobule II, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.08178
CTCF-20526341-ESCS-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(o-18:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K60662039	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.62743
GSE235066_4_v_2_cisplatin_human	RummaGEO Drug Perturbation Signatures	1.0	null
organophosphate biosynthetic process	GO Biological Process Annotations 2015	1.0	null
PC(P-18:1(9Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.WT.HP_24H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.4331
CardiacMyocytes	BioGPS Human Cell Type and Tissue Gene Expression Profiles	1.0	1.04258
Obesity	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.054
PC(18:3(9Z,12Z,15Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K44042747	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.56511
umbilicalcord	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	1.0	0.913653
primary motor cortex (area M1, area 4)_30 yrs_F_12290	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.11444
Lung adenocarcinoma_LUAD_TCGA-44-3918-01A-01R-1107-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-449a	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.0155
GSE231799_3_v_5_nfkbie_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
r4 part of cochlear sensory column	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.31971
Lung adenocarcinoma_LUAD_TCGA-MP-A4T9-01A-11R-A24X-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Lung squamous cell carcinoma_LUSC_TCGA-21-1070-01A-01R-0692-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(P-18:1(11Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CiliaryGanglion	BioGPS Human Cell Type and Tissue Gene Expression Profiles	1.0	1.09785
Perturb_14155_KO_KBTBD4_SRP279638	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	-20.0
CRCGN012_HEPG2_24H:J19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.27295
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Ether lipid metabolism	KEGG Pathways 2026	1.0	null
PC(20:2(11Z,14Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Phospholipase A2	InterPro Predicted Protein Domain Annotations	1.0	null
BRD-A50287893	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.86482
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:O01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.47514
PE(20:3(5Z,8Z,11Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
H3K9me3_H1	Roadmap Epigenomics Histone Modification Site Profiles	1.0	null
PE(22:1(13Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
superficial stratum of r1BL	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.35429
BRD-K75539052	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.21345
CRCGN016_MCF10A.WT.HP_24H:H08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.52431
PC(20:3(8Z,11Z,14Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
Pyramus (VIII)	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.17917
PE(18:3(6Z,9Z,12Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
amygdaloid complex_36 yrs_M_12302	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.06316
PC(15:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
NCKIPSD	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.64626
CRCGN014_HEPG2_3H:H09	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.76685
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
NCIH226	CCLE Cell Line Gene Expression Profiles	1.0	1.53416
PC(14:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
GSE65617_0_v_4_aire_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
CRCGN015_MCF10A.WT.HP_24H:M16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.7325
PC(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
primary visual cortex (striate cortex, area V1/17)_30 yrs_F_12290	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.1324
PC(P-16:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.WT.HP_24H:B04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.08915
PC(15:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K81471597	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.19026
PC(20:3(8Z,11Z,14Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-762	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.880544
prepontine hindbrain	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.42233
CRCGN009_HEPG2_24H:F20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	9.5907
BRD-K93624320	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.16204
Hypotrichosis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.547
PC(20:4(8Z,11Z,14Z,17Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Metabolism	Reactome Pathways 2024	1.0	null
LysoPC(16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE139455_2_v_3_stat3_human	RummaGEO Gene Perturbation Signatures	1.0	null
CRCGN015_MCF10A.WT.HP_24H:M07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.13789
CRCGN008_HEPG2_24H:C22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.05565
hiv	GAD Gene-Disease Associations	1.0	null
PC(o-18:1(9Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PMC3879300-pone.0084292.s002.xlsx-SPD_dataset-Gene_symbol_HOXD13	Rummagene Transcription Factor Associations 2026	1.0	null
PE(22:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP	GWAS Catalog SNP-Phenotype Associations 2025	1.0	2.5699
CRCGN015_MCF10A.WT.HP_24H:J10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.55484
NCI-H1355	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.42739
Pancreatic adenocarcinoma_PAAD_TCGA-YB-A89D-01A-12R-A36G-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(18:1(9Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
hippocampus (hippocampal formation)_3 yrs_F_12836	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.20396
BRD-K90882192	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.0497
skin	GTEx Tissue Gene Expression Profiles	1.0	1.25744
PE(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
A3/KAW	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.80454
inferolateral temporal cortex (area TEv, area 20)_37 yrs_M_12303	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-2.17256
BRD-K14961381	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.44722
mantle zone of r5BM	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.04817
orbital frontal cortex_15 yrs_M_12299	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.992644
Lymphoma_burkitts(Raji)	BioGPS Human Cell Type and Tissue Gene Expression Profiles	1.0	0.999129
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K54879095	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.37835
PMC3102637-1471-2105-12-99-S2.XLSX-11_sigpathways_in_AA_P_0_001-Unnamed_65_TEAD1	Rummagene Transcription Factor Associations 2026	1.0	null
PE(18:1(9Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K92172862	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.00721
BRD-K85357344	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.94266
GSE180200,GSE180201_15_v_11_qpctl_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.WT.HP_24H:C07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.53417
intracellular part	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.237908
SK-MM-2	GDSC Cell Line Gene Expression Profiles	1.0	1.48273
PC(18:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
HIV Infections	HuGE Navigator Gene-Phenotype Associations	1.0	null
BRD-K14671808	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.25641
PE(14:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
496100461_PCx_possible Alzheimer's disease_TBI_89_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	6.22894
adenocarcinoma	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.158097
PE(20:3(5Z,8Z,11Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
Stat6	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	27.284
cell part	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.237908
BRD-K66425065	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.84976
HCC1428	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	-1.0	-2.24165
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Adrenocortical carcinoma_ACC_TCGA-OR-A5J2-01A-11R-A29S-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
fc epsilon ri signaling pathway	KEGG Pathways	1.0	null
RAD21-21589869-MESCS-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
primary motor cortex (area M1, area 4)_2 yrs_F_12979	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.79875
Simple lobule, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.95325
PE(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
YH-13	GDSC Cell Line Gene Expression Profiles	1.0	2.23922
BRD-K83294522	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.17066
PC(20:3(5Z,8Z,11Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN010_HEPG2_24H:C21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.47472
FOXA1	ENCODE Transcription Factor Targets	1.0	null
PE(22:1(13Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
KDM5A	ENCODE Transcription Factor Targets	1.0	null
PC(P-16:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:J17	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	8.20638
PKNOX2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	41.7988
PC(18:3(6Z,9Z,12Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
GF1B-26923725-CHIP-SEQ-HPCS-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
Human - Tonsil - L2 - Surface epithelium	HuBMAP Azimuth Cell Type Annotations	1.0	null
cerebellar cortex_4 yrs_M_12298	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.37176
PC(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-A77164655	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.51649
SNU-16	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.74311
CAL78	CCLE Cell Line Gene CNV Profiles	1.0	1.63501
PE(18:1(11Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_3H:C06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.49213
POLR2AphosphoS5_MEL cell line_mm9_2	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-QK-A652-01A-11R-A30B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K66207462	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.74327
BRD-K15378071	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.0361
Artery disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.325
GSE216043_7_v_9_cisplatin_human	RummaGEO Drug Perturbation Signatures	-1.0	null
ZXDC_KD_GDS5070_504_human_U937	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
KYSE-70	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	2.17033
GSE239844_7_v_10_crizotinib_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PSMG3	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	-1.0	-2.2836
Lung adenocarcinoma_LUAD_TCGA-05-4417-01A-22R-1858-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
lipase activity	GO Molecular Function Annotations 2015	1.0	null
LysoPC(22:0)	HMDB Metabolites of Enzymes	1.0	null
LysoPC(20:0)	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-55-8508-01A-11R-2403-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
NCIH1436	CCLE Cell Line Gene Expression Profiles	-1.0	-2.16038
MOLM-16	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.95283
Kidney renal clear cell carcinoma_KIRC_TCGA-B8-5552-11A-01R-1672-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(20:3(8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PMC12304111-41598_2025_13196_MOESM5_ESM.xlsx-Sheet_1-Table_S4_DEGs_Log2FC_1_and_p_adj_0_05_in_pancreatic_cancer_with_high_versus_low_OVOL1_expression_OVOL1	Rummagene Transcription Factor Associations 2026	1.0	null
PE(22:2(13Z,16Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
EZH2_myotube_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
dorsolateral prefrontal cortex_1 yrs_F_12830	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.09304
BRD-K30594227	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.58323
PC(o-22:2(13Z,16Z)/22:3(10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K37019305	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.46321
FTC-133	GDSC Cell Line Gene Expression Profiles	-1.0	-1.57311
BRD-K03221986	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.00631
NUP58	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.07763
Pheochromocytoma and Paraganglioma_PCPG_TCGA-SQ-A6I4-01A-11R-A35L-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(24:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
organic substance metabolic process	GO Biological Process Annotations 2015	1.0	null
GSE60837_6_v_3_bcl9_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
CRCGN009_HEPG2_24H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.78955
Rectum adenocarcinoma_READ_TCGA-G5-6233-01A-11R-1736-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(16:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
decreased body weight	IMPC Knockout Mouse Phenotypes	1.0	null
glycerophospholipid biosynthetic process	GO Biological Process Annotations 2015	1.0	null
FADU	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.03878
YY1	MotifMap Predicted Transcription Factor Targets	1.0	null
PC(18:2(9Z,12Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
496100445_HIP_no dementia_no TBI_90-94_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	3.42106
STAT3	MotifMap Predicted Transcription Factor Targets	1.0	null
r5 part of magnocellular medial vestibular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.12647
PE(22:1(13Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
H3K27ac_MCF-7_hg19_1	ENCODE Histone Modification Site Profiles	1.0	null
CRCGN016_MCF10A.TP53.M_24H:A16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.2962
BRD-K88613983	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.4518
GSE119345_2_v_3_bexarotene_human	RummaGEO Drug Perturbation Signatures	-1.0	null
CRCGN011_HEPG2_24H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.2223
PMC9437808-mmc3.xlsx-IPA_Upstream_regulators-IPA_Upstream_regulator_analysis_Up_regulated_genes_following_LPS_treatment_IRF6	Rummagene Transcription Factor Associations 2026	1.0	null
high-density lipoprotein particle	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.728
PE(14:1(9Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K54939987	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.69783
PC(18:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE151829,GSE151831_5_v_8_aire_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PC(14:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
cardiovascular system disease	GWASdb SNP-Disease Associations	1.0	0.808756
Skin Cutaneous Melanoma_SKCM_TCGA-EB-A3XD-01A-22R-A239-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Contact dermatitis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.595
hippocampus (hippocampal formation)_18 yrs_M_12984	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.97868
PC(22:1(13Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN013_HEPG2_24H:I13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.99684
HCC2935	DepMap CRISPR Gene Dependency	1.0	2.5424
Interpeduncular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.09305
Organ system cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.188
LysoPC(18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:O10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.59672
DMS79	CCLE Cell Line Gene CNV Profiles	1.0	1.40326
PC(20:1(11Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
CAL-51	COSMIC Cell Line Gene Mutation Profiles	1.0	null
Lateral reticular nucleus, magnocellular part	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.0401
PC(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GSE180200,GSE180201_15_v_1_qpctl_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
CRCGN017_MCF10A.WT.HP_24H:P19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.2349
Skeletal Muscle Male	Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles	-1.0	-0.828004
EJM	DepMap CRISPR Gene Dependency	1.0	2.79575
GSK3B_knockdown_209_GSE35351	GEO Signatures of Differentially Expressed Genes for Kinase Perturbations	1.0	1.6052
extracellular region	GO Cellular Component Annotations 2015	1.0	null
PC(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
NR1I2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	31.1875
PC(18:1(11Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.WT.HP_24H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.4825
hsa-let-7f	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.40969
PC(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Folium-tuber vermis (VII), molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.31872
cytosol	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.237908
PE(16:1(9Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN011_HEPG2_24H:A09	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.4332
isoforms	GeneRIF Biological Term Annotations	1.0	null
Atoh1	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	23.1821
BRD-K38424085	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.4042
GSE230354_0_v_1_rheb_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(20:3(8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
ZSCAN16	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	42.8965
RT4	CCLE Cell Line Gene Expression Profiles	1.0	3.40793
Brain Lower Grade Glioma_LGG_TCGA-DU-A5TY-01A-11R-A28M-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K05409106	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.40878
PMC11615365-41467_2024_54246_MOESM5_ESM.xlsx-RT112-Numb-KD_vs_Ctr-KD-geneSymbol_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K31721388	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.15976
PC(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Sebaceous gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.991
Daudi	GDSC Cell Line Gene Expression Profiles	1.0	1.82016
PMC6167382-41467_2018_6258_MOESM4_ESM.xlsx-TEAD-associated_GSC-Specific_UP-Nearest_Ensembl_GSC	Rummagene Transcription Factor Associations 2026	1.0	null
496100394_TCx_probable Alzheimer's disease_no TBI_85_M	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	2.23327
PC(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4689	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.7397
hsa-let-7c	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
PE(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
LU-65	GDSC Cell Line Gene Expression Profiles	1.0	1.85406
BRD-K36718828	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.28742
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
ISTMEL1	DepMap CRISPR Gene Dependency	1.0	6.29411
BRD-K92444813	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.2127
BRD-K87080069	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.41543
PC(22:2(13Z,16Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H510A	COSMIC Cell Line Gene CNV Profiles	1.0	3.12177
BRD-K97943226	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.28548
animal	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.05555
MHHCALL4	CCLE Cell Line Gene Expression Profiles	1.0	1.51926
ESR1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	27.7902
ventrolateral prefrontal cortex_36 yrs_M_12302	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.04895
ChIP_NACC1_18358816	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
FOXA1-25552417-VCAP-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.TP53.M_24H:A13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.78813
Head and Neck squamous cell carcinoma_HNSC_TCGA-CV-7183-01A-11R-2016-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(14:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-CV-7413-01A-11R-2081-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Bronchial disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.06
BRD-K59188100	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.15776
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
Liver hepatocellular carcinoma_LIHC_TCGA-ZP-A9CY-01A-11R-A38B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
capillary endothelium	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.697808
PC(18:1(11Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K83115435	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.5529
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
KMM-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.18897
PE(22:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-E5-A4U1-01A-11R-A31N-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
single-organism biosynthetic process	GO Biological Process Annotations 2015	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K76723780	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.23125
SW 1573	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.5504
hsa-miR-3183	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.880544
MAX	ENCODE Transcription Factor Targets	1.0	null
PC(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:G15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.61831
PE(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K76400756	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.22489
PE(22:4(7Z,10Z,13Z,16Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
endocrine gland	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
upper	GeneRIF Biological Term Annotations	1.0	null
PE(18:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
r3 part of basomedial reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.01468
PC(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN008_HEPG2_24H:O02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.4798
PC(24:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GLIS2	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.62894
small testis	IMPC Knockout Mouse Phenotypes	1.0	null
G140	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.929214
intermediate stratum of r10BM	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.19721
PE(14:1(9Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K08715132	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.12098
TE15	CCLE Cell Line Gene Expression Profiles	-1.0	-1.57821
PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
artery wall	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.148856
KO52	CCLE Cell Line Gene CNV Profiles	1.0	1.55583
PE(16:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PMC5342415__F3	PFOCR Pathway Figure Associations 2024	1.0	null
GSE236454,GSE236456_0_v_1_angiotensin ii_mouse	RummaGEO Drug Perturbation Signatures	1.0	null
phosphatidylcholine metabolic process	GO Biological Process Annotations 2025	1.0	null
PE(16:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(dm18:1(9Z)/dm18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
MYF5	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	24.4842
CRCGN008_HEPG2_24H:L03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.3594
PE(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE123734_1_v_0_mien1_human	RummaGEO Gene Perturbation Signatures	1.0	null
Keratinocyte cell line	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.231
Arachidonic acid metabolism	KEGG Pathways 2026	1.0	null
GSE80098,GSE80366_0_v_4_progesterone_human	RummaGEO Drug Perturbation Signatures	1.0	null
Skin cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.536
HUNS1	CCLE Cell Line Gene Expression Profiles	1.0	1.85246
PE(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
r10 part of basointermediate reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.2679
BRD-K05474024	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.88863
intestinal cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.049501
PC(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
ESR2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	25.6288
PE(22:4(7Z,10Z,13Z,16Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:C24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.51333
PE(20:2(11Z,14Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN008_HEPG2_24H:O01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.77275
PE(20:3(5Z,8Z,11Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-22:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
KU-19-19	GDSC Cell Line Gene Expression Profiles	-1.0	-1.66082
BRD-A68842442	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.02303
BRD-K29662589	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.09966
Macrophage foam cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.01
PE(20:4(8Z,11Z,14Z,17Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
negative regulation of T cell activation	GO Biological Process Annotations 2025	1.0	null
r9 part of dorsal parvicellular reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.54784
cell part	GO Cellular Component Annotations 2015	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
OAW28	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.928367
BRD-K15930345	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.33756
PC(18:3(9Z,12Z,15Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
FOXA1-21915096-LNCAP-1F5-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PE(20:2(11Z,14Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Cardiovascular system disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.271
PC(P-18:1(9Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Phospholipid metabolism	Reactome Pathways 2024	1.0	null
anterior (rostral) cingulate (medial prefrontal) cortex_1 yrs_F_12830	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.931217
PC(20:1(11Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-20:1(11Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
ETV5::FIGLA	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	40.4345
BCPAP	CCLE Cell Line Gene CNV Profiles	1.0	1.54259
BRD-K57786075	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.06443
PMC9124206-41419_2022_4940_MOESM8_ESM.xlsx-DEG_PACA-CA-geneName_PTF1A	Rummagene Transcription Factor Associations 2026	1.0	null
PE(15:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K05246869	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.10461
r10 part of dorsal parvicellular reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.69029
PE(20:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CTCF-27219007-CHIP-SEQ-BCELLS-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
BRD-K43872193	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.67934
SW684	GDSC Cell Line Gene Expression Profiles	-1.0	-1.41837
PC(P-18:1(11Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
r6 part of the basolateral reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.58924
PE(24:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
tendon	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.374993
PE(22:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
RBPJ-21746931-IB4-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
H3K27me3_Rectal Smooth Muscle	Roadmap Epigenomics Histone Modification Site Profiles	1.0	null
Metabolism	dbGAP Gene-Trait Associations	1.0	0.1696
PC(22:5(4Z,7Z,10Z,13Z,16Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PMC12214745-41598_2025_95903_MOESM1_ESM.pdf-6-PKNOX1_PKNOX1	Rummagene Transcription Factor Associations 2026	1.0	null
tissues, cell types and enzyme sources	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.055027
RMG-I	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.51918
CRCGN015_HEPG2_48H:M16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	8.20265
Liver hepatocellular carcinoma_LIHC_TCGA-DD-A11A-01A-11R-A131-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
NBSUSSR	COSMIC Cell Line Gene Mutation Profiles	1.0	null
ae2	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.892
CRCGN014_HEPG2_24H:H13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.73448
Thymus	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
PE(20:4(5Z,8Z,11Z,14Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K28006645	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.62779
basal reticular formation of p1	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.33678
BRD-K42506600	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.159
PC(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
r2 part of dorsal cochlear nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.14584
BRD-K83553001	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.27507
cellular biogenic amine metabolic process	GO Biological Process Annotations 2015	1.0	null
BRD-K24565713	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.76173
CRCGN012_HEPG2_24H:D01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.35578
BRD-K17910820	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.29103
PE(16:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K50117485	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.02392
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4498	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.880544
PMC3610249-1471-2164-14-184-S4.xls-miR-331-3p_targets-NR2E3_NR2E3	Rummagene Transcription Factor Associations 2026	1.0	null
ethanolamine-containing compound metabolic process	GO Biological Process Annotations 2015	1.0	null
BRD-K83090041	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.01015
PC(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.WT.HP_24H:G06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.65747
PE(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CCK81	DepMap CRISPR Gene Dependency	1.0	2.08388
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-634	TargetScan Predicted Conserved microRNA Targets	1.0	0.248923
PC(16:1(9Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-U28903152	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.00124
NCIH2081	CCLE Cell Line Gene Expression Profiles	-1.0	-1.61113
BRD-K48541282	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.04484
GATA6-21074721-CACO-2-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
ZNF582	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	40.2423
orbital frontal cortex_4 mos_M_12296	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-0.860992
gastrointestinal system cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.042848
PC(24:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
NFYB-21822215-K562-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
Prostate adenocarcinoma_PRAD_TCGA-CH-5753-01A-11R-1580-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(16:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
H3K4me1_mammary epithelial cell_hg19_1	ENCODE Histone Modification Site Profiles	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
18801183-SuppTable1	GeneSigDB Published Gene Signatures	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
Immune system	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
Perturb_14669_KO_Prkaa1/Prkaa2_ERP006813	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	-1.0	-13.794
PC(P-18:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
TCF3	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	24.5905
CRCGN008_HEPG2_24H:L04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.8872
GSE216043_7_v_8_cisplatin_human	RummaGEO Drug Perturbation Signatures	-1.0	null
ventrolateral part of m2A	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.45181
nitrogen compound metabolic process	GO Biological Process Annotations 2015	1.0	null
BRD-K89650689	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.14313
GSE166920_6_v_1_adalimumab_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(18:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(O-16:1(1Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
phospholipid metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(18:3(9Z,12Z,15Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
carboxylic ester hydrolase activity	GO Molecular Function Annotations 2015	1.0	null
Pancreatic adenocarcinoma_PAAD_TCGA-IB-7654-01A-11R-2156-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-G2-A3IE-01A-11R-A20F-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Yy1	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	18.1734
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
1-Organyl-2-lyso-sn-glycero-3-phosphocholine	MW Enzyme Metabolite Associations	1.0	null
BRD-K60758969	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.96827
Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A47V-01A-11R-A23W-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(22:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
digits	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	1.0	1.46784
PE(20:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.WT.HP_24H:O01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.07251
medial part of r7B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.75075
NCI-H292	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-2.28242
PE(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidylethanolamine acyl-chain remodeling	GO Biological Process Annotations 2025	1.0	null
hydrolase activity, acting on ester bonds	GO Molecular Function Annotations 2015	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
hippocampus (hippocampal formation)_17 pcw_F_12880	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.03486
PE(15:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
negative regulation of lymphocyte proliferation	GO Biological Process Annotations 2023	1.0	null
Cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.209
NEUROD1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	25.2125
PC(22:4(7Z,10Z,13Z,16Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
dorsolateral part of Lat	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.18021
mantle zone of r9BL	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.52833
Lung adenocarcinoma_LUAD_TCGA-50-6594-01A-11R-1755-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
TP53INP1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.4926
PC(P-18:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A_48H:H22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.5044
LysoPC(15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K50291875	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.71077
NCIH1944	CCLE Cell Line Gene CNV Profiles	-1.0	-1.46955
PANC0213	CCLE Cell Line Gene Expression Profiles	-1.0	-3.04545
PE(16:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
NANOG	ChEA Transcription Factor Targets	1.0	null
BRD-K93755725	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.76968
BRD-K53489056	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.14788
HCC2998	BioGPS Cell Line Gene Expression Profiles	-1.0	-1.26891
PE(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K87602457	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.08993
CRCGN008_HEPG2_24H:O04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.8773
PE(15:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K68495784	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.00327
Tongue	BioGPS Human Cell Type and Tissue Gene Expression Profiles	1.0	0.842016
PC(15:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
canthaxanthin	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.00111
BRD-K04358482	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.13596
GSE201239_6_v_1_fmr1_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
posteroventral (inferior) parietal cortex_18 yrs_M_12984	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.29132
PC(24:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
RUNX3	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	18.2256
KMS-28BM	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.62501
TP53-22573176-HFKS-HUMAN	ChEA Transcription Factor Binding Site Profiles	1.0	null
PC(24:1(15Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K82765368	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.23563
ZNF217_MCF-7_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PC(P-18:1(9Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(dm18:1(9Z)/dm18:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.WT.HP_24H:D05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.59265
PC(22:1(13Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
EFM-192C	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.913308
CRCGN014_HEPG2_24H:K23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.82635
PC(P-18:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Nkx2-1	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	22.3581
PC(P-18:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-CV-5973-01A-11R-1686-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(18:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
KPNYN	CCLE Cell Line Gene CNV Profiles	-1.0	-1.46556
PC(P-18:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
HG3	DepMap CRISPR Gene Dependency	1.0	4.11067
CRCGN009_HEPG2_24H:N19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.32724
CRCGN011_HEPG2_24H:O02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.2988
NCIH524	CCLE Cell Line Gene Expression Profiles	-1.0	-1.56739
BRD-K97949309	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.10546
BRD-K94616959	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.15397
LysoPC(22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-55-7728-01A-11R-2187-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CRCGN015_HEPG2_48H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.74086
r4 liminal central gray	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.03641
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
SW 1417	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.03978
synovial tissue	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.40328
BRD-K04559718	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.56712
PC(20:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
GSE169356_2_v_1_ivermectin_human	RummaGEO Drug Perturbation Signatures	-1.0	null
CRCGN015_HEPG2_48H:K08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.15752
PE(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidylglycerol acyl-chain remodeling	GO Biological Process Annotations 2025	1.0	null
amygdaloid complex_21 pcw_F_12365	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.911999
PC(22:2(13Z,16Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
mantle zone of r3Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.25749
PC(18:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-661	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
PC(22:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H1648	COSMIC Cell Line Gene Mutation Profiles	1.0	null
PE(24:1(15Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CBX2-22325352-293T-REX-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GSE182680,GSE182683_0_v_9_dexamethasone_human	RummaGEO Drug Perturbation Signatures	1.0	null
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-VS-A954-01A-11R-A38B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
VMRC-LCD	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.2753
PE(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Hair disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.508
PC(14:1(9Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(dm18:1(11Z)/dm18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE174498,GSE174500_0_v_1_asparaginase_human	RummaGEO Drug Perturbation Signatures	1.0	null
r3 part of anteroventral cochlear nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.12377
PC(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
NFIC	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	48.1395
PC(P-18:1(9Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(dm18:1(9Z)/dm16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
GSE131903_0_v_2_abca12_human	RummaGEO Gene Perturbation Signatures	-1.0	null
496100337_HIP_possible Alzheimer's disease_no TBI_100+_M	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	5.16072
Lung squamous cell carcinoma_LUSC_TCGA-85-8350-01A-11R-2296-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K32251128	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.73444
molecular layer of CbVCx	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.2789
WM793	DepMap CRISPR Gene Dependency	1.0	2.28532
BRD-K62841356	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.42417
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
NCIH510	CCLE Cell Line Gene CNV Profiles	1.0	2.69369
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
MCC13	COSMIC Cell Line Gene Mutation Profiles	1.0	null
CRCGN013_HEPG2_24H:K13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.10685
increased mean platelet volume	IMPC Knockout Mouse Phenotypes	1.0	null
Oliver-McFarlane syndrome	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.012
PC(14:1(9Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
Flocculus, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.79734
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
lung	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
THRA	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	66.8681
CRCGN012_HEPG2_24H:O02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.87226
PE(14:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4784	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.7397
PC(18:3(9Z,12Z,15Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
GSE65617_2_v_3_aire_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
BRD-K87258738	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.35829
CRCGN016_MCF10A.WT.HP_24H:M01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.93308
MCF10A	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	1.0	0.706601
PMC6775191__F8	PFOCR Pathway Figure Associations 2023	1.0	null
PC(18:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K97256018	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.09815
PE(22:1(13Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K34907403	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.32293
thymus	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
BRD-K97707303	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.28915
Rectal Mucosa Donor 31	Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles	-1.0	-0.962798
intermediate stratum of r6BM	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-2.03534
Stratum granulosum	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.318
CRCGN016_MCF10A.WT.HP_24H:K11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.05221
PE(20:3(8Z,11Z,14Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Sarcoma_SARC_TCGA-MB-A8JL-01A-11R-A36F-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K51843685	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.03739
BRD-K38917645	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.27921
TGIF2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	40.9039
PC(o-16:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
Sarcoma_SARC_TCGA-QQ-A5VD-01A-21R-A32Q-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
phosphatidylserine acyl-chain remodeling	GO Biological Process Annotations 2015	1.0	null
LysoPC(20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
barrier	GeneRIF Biological Term Annotations	1.0	null
PE(20:1(11Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Foam cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.075
CRCGN008_HEPG2_24H:G15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.79265
PE(14:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Zfp809	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	36.9718
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K00883748	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.01384
PC(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
K-562	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.28916
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
STAT3-23295773-U87-HUMAN	ChEA Transcription Factor Binding Site Profiles	1.0	null
SCRT2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	20.2202
Head and Neck squamous cell carcinoma_HNSC_TCGA-D6-6825-01A-21R-1915-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
GSE157296,GSE157298_4_v_3_kbtbd4_human	RummaGEO Gene Perturbation Signatures	1.0	null
BRD-K13110820	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.73481
medial part of r5B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.04628
PC(20:2(11Z,14Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
KMS34	DepMap CRISPR Gene Dependency	1.0	5.70401
p1B part of the periaqueductal gray	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.79079
Pou5f1::Sox2	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	24.8248
PC(22:1(13Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K07482874	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.3426
SUPT11	CCLE Cell Line Gene CNV Profiles	1.0	1.86974
Lung squamous cell carcinoma_LUSC_TCGA-22-A5C4-01A-12R-A27Q-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K97263385	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.26306
PC(22:4(7Z,10Z,13Z,16Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
RT112	CCLE Cell Line Gene Expression Profiles	1.0	2.65491
PE(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
GSE153484_2_v_0_foxp3_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
Brain Lower Grade Glioma_LGG_TCGA-S9-A7R7-01A-11R-A34R-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K32983008	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.70974
PC(P-18:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
D425	DepMap CRISPR Gene Dependency	1.0	2.70318
Brain Lower Grade Glioma_LGG_TCGA-VV-A829-01A-21R-A36H-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Lobule III, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.23021
r8 part of basointermediate reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.29463
CRCGN010_HEPG2_24H:O02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.96516
PE(18:1(9Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GSE155305_2_v_1_ifitm3_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
1321N1	CCLE Cell Line Gene CNV Profiles	1.0	1.45443
PE(14:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE196671_5_v_1_obox4_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PC(20:3(5Z,8Z,11Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
Parabrachial nucleus, medial division, external medial part	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.33134
PMC11615365-41467_2024_54246_MOESM5_ESM.xlsx-RT112-Numb-KD_vs_Ctr-KD-ensemblGeneId_AR	Rummagene Transcription Factor Associations 2026	1.0	null
CRCGN015_MCF10A.WT.HP_24H:P19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.06758
PE(20:1(11Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-4J-AA1J-01A-21R-A38B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
OVTOKO	DepMap CRISPR Gene Dependency	1.0	3.8305
PE(18:2(9Z,12Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Amylin receptor complex 1	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.972
CRCGN009_HEPG2_24H:M19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.4362
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
mantle zone of r4Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.31938
carboxylic ester hydrolase activity	GO Molecular Function Annotations 2023	1.0	null
GSE122215,GSE122217_0_v_1_peg10_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PE(22:2(13Z,16Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
ZNF280D	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	4.13373
NCIH1092	CCLE Cell Line Gene CNV Profiles	1.0	1.40873
RBBP5_K562_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PC(18:1(9Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.WT.HP_24H:E07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.0898
plasma lipoprotein particle	COMPARTMENTS Text-mining Protein Localization Evidence Scores	1.0	0.085758
GSE164529_0_v_1_tamoxifen_human	RummaGEO Drug Perturbation Signatures	1.0	null
hsa-miR-579	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
PUR1	MotifMap Predicted Transcription Factor Targets	1.0	null
MDA MB435	BioGPS Cell Line Gene Expression Profiles	1.0	1.25721
CRCGN011_HEPG2_24H:O05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.29635
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE196671_5_v_0_obox4_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(20:3(5Z,8Z,11Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
HCC1500	COSMIC Cell Line Gene Mutation Profiles	1.0	null
hsa-let-7i	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.40969
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K26184956	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.21058
BRD-K02545368	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.14623
enlarged heart	IMPC Knockout Mouse Phenotypes	1.0	null
PC(20:1(11Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H2795	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-2.01693
PE(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K05635176	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.4692
CRCGN015_HEPG2_48H:J23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.91947
PE(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:F21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.21667
Hair shaft	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.076
Fat digestion and absorption	KEGG Pathways 2026	1.0	null
PC(15:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PMC8995879-Table_1.xlsx-exome_variants_MAF_0_01-Gencode_34_hugoSymbol_MAF	Rummagene Transcription Factor Associations 2026	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K90311252	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.00037
CRCGN011_HEPG2_24H:C22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.40845
adrenalgland	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	1.0	0.908183
GSE133070_3_v_1_prss1_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
metabolic	GAD High Level Gene-Disease Associations	1.0	0.293278
PE(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
cytoplasmic part	GO Cellular Component Annotations 2015	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
CAPAN-2	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.03698
PE(20:4(8Z,11Z,14Z,17Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K95153342	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.01509
PC(P-18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K65440031	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.36905
PC(o-20:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN010_HEPG2_24H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.53805
hsa-miR-4458	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.40969
PC(dm16:0/dm18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K44975377	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.0225
PE(14:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
Liver hepatocellular carcinoma_LIHC_TCGA-BC-A10U-01A-11R-A131-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CRCGN015_HEPG2_48H:G13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.61007
BXPC-3	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.929214
Paneth cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.091
MSC	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	27.2972
CRCGN014_HEPG2_3H:H05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.83333
PE(14:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(dm18:1(9Z)/dm18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-HT-8011-01A-11R-2403-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:P01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.40931
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
GSE193258,GSE193259_5_v_13_osimertinib_human	RummaGEO Drug Perturbation Signatures	-1.0	null
TWIST1_01_254	KnockTF Gene Expression Profiles with Transcription Factor Perturbations	1.0	2.10673
viscus	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.051671
PE(20:1(11Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidylcholine acyl-chain remodeling	GO Biological Process Annotations 2015	1.0	null
PC(20:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GSE196199_0_v_1_zbtb20_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(18:2(9Z,12Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K68301602	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.15511
BRD-K53088255	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.36551
mantle zone of p1Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.08485
PE(16:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
E2A	MotifMap Predicted Transcription Factor Targets	1.0	null
A-498	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.44227
Declive (VI), molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.53885
PC(20:3(8Z,11Z,14Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Medullary reticular nucleus, ventral part	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.87918
cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.039748
Water	HMDB Metabolites of Enzymes	1.0	null
CRCGN008_HEPG2_24H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.7401
PC(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Pheochromocytoma and Paraganglioma_PCPG_TCGA-S7-A7X0-01A-12R-A35L-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(20:2(11Z,14Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
NFYA-21822215-K562-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
MHH-ES-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.51605
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K82968130	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.60818
PE(20:3(5Z,8Z,11Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
MM1S	DepMap CRISPR Gene Dependency	1.0	2.46379
SKNDZ	DepMap CRISPR Gene Dependency	1.0	3.16093
PE(20:3(8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
tissues, cell types and enzyme sources	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
hsa-miR-423-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.0155
Inhibin A complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.609
BRD-K44328896	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.2127
PC(P-18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE235066_7_v_2_cisplatin_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(18:1(11Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
X-linked ichthyosis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.04
PC(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
p1 part of the substantia nigra reticulata	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.28067
BRD-K53026281	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.896
CRCGN012_HEPG2_24H:J21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.49213
PC(22:5(4Z,7Z,10Z,13Z,16Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
Perturb_16476_KD_Ripk4_SRP173803	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	-1.0	-3.5797
metal ion binding	GO Molecular Function Annotations 2015	1.0	null
mantle zone of r6Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.04317
PE(20:1(11Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
mantle zone of r6BM	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.95396
r9 part of basomedial reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.04691
PE(18:3(9Z,12Z,15Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
cellular amine metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
SUIT2	CCLE Cell Line Gene CNV Profiles	-1.0	-1.33649
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
Lung squamous cell carcinoma_LUSC_TCGA-58-8386-01A-11R-2296-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
ventrolateral prefrontal cortex_18 yrs_M_12984	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.47874
PE(22:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
amine metabolic process	GO Biological Process Annotations 2015	1.0	null
GSE190864,GSE190907_1_v_0_cacybp_human	RummaGEO Gene Perturbation Signatures	-1.0	null
BRD-K62976536	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.14438
GSE65617_5_v_3_aire_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
STAT5A	ChEA Transcription Factor Targets	1.0	null
Perturb_3817_KO_Atoh1_SRP076034	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	-1.0	-20.0
PC(24:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN013_HEPG2_24H:C22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.54707
all	GWASdb SNP-Phenotype Associations	1.0	0.028711
PE(18:1(11Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
periventricular stratum of CbH	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.96775
r2 part of cochlear sensory column	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.29206
molecular_function	GO Molecular Function Annotations 2015	1.0	null
PC(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
Corneocyte	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.717
STAT5-23275557-MAMMARY-EPITHELIUM-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-P5-A5F6-01A-11R-A28M-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(P-18:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
SUPHD1	CCLE Cell Line Gene CNV Profiles	-1.0	-1.94007
PE(24:1(15Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Pheochromocytoma and Paraganglioma_PCPG_TCGA-W2-A7H7-01A-11R-A35L-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4492	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.843347
PC(P-18:1(9Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:L11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.39975
GSE264621_1_v_3_secretin_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K36689392	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.30906
PC(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:C20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.65727
BRD-K81181894	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.03812
BRD-K46742113	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.01569
SK-MEL-3	COSMIC Cell Line Gene Mutation Profiles	1.0	null
PC(14:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:C01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.2943
PC(16:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
496100520_HIP_no dementia_TBI_95-99_M	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	5.46119
PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:P05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.3019
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
NKX2-3	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	16.6863
CTCF	ENCODE Transcription Factor Targets	1.0	null
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-DG-A2KJ-01A-11R-A32Y-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(15:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
Psoriasis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.855
PC(18:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PrPC_KO_GDS4352_358_mouse_Developing hippocampus from FVB newborns (4.5-day-old)	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	null
b-lymphocyte	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.078999
PE(15:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K94506829	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.12783
Acquired metabolic disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.015
Gigantocellular reticular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.8382
PC(22:2(13Z,16Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
r1 part of intermediate nucleus of the lateral lemniscus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.35605
PC(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:C07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.4213
hippocampus (hippocampal formation)_40 yrs_F_12304	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.93047
PE(22:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
negative regulation of lymphocyte proliferation	GO Biological Process Annotations 2025	1.0	null
PE(24:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
EMTOKA	DepMap CRISPR Gene Dependency	1.0	2.69255
BRD-K92195351	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.44645
Lung squamous cell carcinoma_LUSC_TCGA-43-6771-01A-11R-1820-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Kidney renal papillary cell carcinoma_KIRP_TCGA-HE-7130-01A-11R-1965-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
pretectal tegmentum	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.14995
PE(20:3(8Z,11Z,14Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
posterior (caudal) superior temporal cortex (area 22c)_3 yrs_M_12980	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.42953
BRD-K90052868	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.2261
CREB1	JASPAR Predicted Transcription Factor Targets	1.0	null
leukocyte	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.053277
Disease of metabolism	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.183
GSE172494_3_v_1_nicotinamide_human	RummaGEO Drug Perturbation Signatures	-1.0	null
PE(24:1(15Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-635	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.921135
PE(18:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
FERD3L	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	49.3117
cardiovascular system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.070693
hsa-miR-4723-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.921135
large intestine	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.06527
NCI H226	BioGPS Cell Line Gene Expression Profiles	1.0	1.04587
mapk signaling pathway	KEGG Pathways	1.0	null
PE(15:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
KINGS1	DepMap CRISPR Gene Dependency	1.0	2.41002
TBL1-22424771-293T-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
BRD-K38111331	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.7229
PE(24:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
A375SKINCJ3	DepMap CRISPR Gene Dependency	1.0	2.97441
Phosphatidylethanolamine	MW Enzyme Metabolite Associations	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
SKMEL28	CCLE Cell Line Gene CNV Profiles	1.0	1.78405
PE(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
143B	CCLE Cell Line Gene Expression Profiles	-1.0	-1.69002
HCC1569	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.18897
Synthesis of PA	Reactome Pathways 2014	1.0	null
Perturb_14160_KD_IPO11_SRP316321	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	8.78405
H3C10	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.01377
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_3H:M21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.529
SNU466	CCLE Cell Line Gene Expression Profiles	1.0	1.49641
ICC12	DepMap CRISPR Gene Dependency	1.0	4.61916
PE(20:3(5Z,8Z,11Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
p1 part of the substantia nigra compacta	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.28646
KYSE-150	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.32498
PE(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:2(9Z,12Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
fallopian tube	GTEx Tissue Gene Expression Profiles	-1.0	-2.00774
PE(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
interstitial cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.447192
PE(22:2(13Z,16Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:O15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.26599
female reproductive gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.071524
CRCGN008_HEPG2_24H:C23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.3552
PC(o-24:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-512-3p	TargetScan Predicted Conserved microRNA Targets	1.0	0.053794
PE(24:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K15609977	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.29501
PE(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.WT.HP_24H:H24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.8383
Purkinje cell layer of CbVCx	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.1847
BRD-K69147598	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.29295
PC(22:1(13Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
NANOG-16518401-MESC-mouse	ChEA Transcription Factor Binding Site Profiles	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-IQ-A6SH-01A-12R-A34R-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(22:2(13Z,16Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K99416393	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.73904
PC(18:3(6Z,9Z,12Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-86-7701-01A-11R-2170-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(22:1(13Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
embryo	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.054483
PC(24:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
HCC1187	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	1.0	0.754122
OCILY19	CCLE Cell Line Gene Expression Profiles	1.0	1.47023
ITK_knockout_242_GSE12465	GEO Signatures of Differentially Expressed Genes for Kinase Perturbations	-1.0	-3.73455
hsa-miR-4420	TargetScan Predicted Conserved microRNA Targets	1.0	0.045136
artery	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.059461
PE(14:1(9Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-55-A494-01A-11R-A24X-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(20:2(11Z,14Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4500	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.55165
PC(18:3(9Z,12Z,15Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GSE196104,GSE196106_2_v_1_vsx2_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
mantle zone of r7BI	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.06763
PE(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN013_HEPG2_24H:O05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.48181
PC(24:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K74701308	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.79515
CRCGN016_MCF10A.WT.HP_24H:O24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.22579
TBX21	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	20.4283
Hoxa11	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	17.9265
PC(18:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CORL24	CCLE Cell Line Gene Expression Profiles	-1.0	-1.75609
PC(18:2(9Z,12Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K62572662	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.00677
PC(18:4(6Z,9Z,12Z,15Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
AU565	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	1.0	0.738445
PC(18:1(11Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K45811188	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.23835
PE(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K82785545	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.23882
CRCGN015_HEPG2_48H:G04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.21652
PE(22:4(7Z,10Z,13Z,16Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidylserine metabolic process	GO Biological Process Annotations 2023	1.0	null
internal granular layer of CbVCx	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.31639
Lobules IV-V, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.46508
BRD-K01667746	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.69605
PC(20:4(8Z,11Z,14Z,17Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
SUDHL10	DepMap CRISPR Gene Dependency	1.0	3.43449
COLO800	CCLE Cell Line Gene Expression Profiles	-1.0	-1.51815
rhombomere 11	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.57362
PC(22:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
ZNF416	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	21.4377
Head and Neck squamous cell carcinoma_HNSC_TCGA-CV-A45O-01A-21R-A24H-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K98876398	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.00202
BRD-K86721033	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.0218
Cardiovascular system	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
p1 part of the pararubral nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.14924
vertebrate muscular system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.070508
PC(P-18:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
8MGBA	CCLE Cell Line Gene Expression Profiles	-1.0	-1.53984
PC(20:3(5Z,8Z,11Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
Prostate adenocarcinoma_PRAD_TCGA-FC-A66V-01A-21R-A30B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CRCGN009_HEPG2_24H:L09	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.18978
PC(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.WT.HP_24H:P10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.29443
liminal alar domain of m2	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.45283
PC(24:1(15Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
disease of anatomical entity	GWASdb SNP-Disease Associations	1.0	0.027628
PET complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.699
ML-2	GDSC Cell Line Gene Expression Profiles	1.0	1.45957
PE(16:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN009_HEPG2_24H:O01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.13843
BRD-K95922469	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.41892
PC(o-18:2(9Z,12Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
disease	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.039434
BRD-K16791544	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.05159
CRCGN015_MCF10A.TP53.M_24H:O07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.3665
CRCGN014_HEPG2_3H:P19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.4714
r9 basal plate	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.25981
GSE217201_1_v_0_asap2_human	RummaGEO Gene Perturbation Signatures	1.0	null
CRCGN014_HEPG2_3H:J22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.64265
HT1376	DepMap CRISPR Gene Dependency	1.0	5.13593
PE(20:1(11Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K06492501	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.02124
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-VS-A8QF-01A-21R-A37O-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
NCIH28	CCLE Cell Line Gene CNV Profiles	-1.0	-1.56137
PE(20:1(11Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
G121	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.862994
PC(20:3(5Z,8Z,11Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K31908823	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.92676
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
Integumentary system disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.655
BRD-K22405104	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.28405
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GSE94849_7_v_0_pinometostat_human	RummaGEO Drug Perturbation Signatures	1.0	null
CRCGN016_MCF10A.WT.HP_24H:A16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.03562
PC(22:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
isthmic alar plate	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.15213
HCC1395	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.01554
LN319	CCLE Cell Line Gene CNV Profiles	1.0	2.26881
KMS28BM	CCLE Cell Line Gene CNV Profiles	1.0	1.85488
PE(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
alditol phosphate metabolic process	GO Biological Process Annotations 2015	1.0	null
r3 part of parvicellular medial vestibular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.42925
PE(22:2(13Z,16Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K99036206	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.09279
PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)e/2:0)	HMDB Metabolites of Enzymes	1.0	null
Paramedian lobule, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.12591
CRCGN011_HEPG2_24H:C24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.639
PE(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
amygdaloid complex_21 yrs_F_13057	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	2.12517
synovium	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.463013
increased mean platelet volume	MGI Mouse Phenotype Associations 2023	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K46641047	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.26062
CRCGN015_MCF10A_48H:J24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.91155
CRCGN015_MCF10A.TP53.M_24H:M07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.5067
PC(14:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-A22502911	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.53539
PC(dm16:0/dm18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE191015_0_v_2_gsdmb_human	RummaGEO Gene Perturbation Signatures	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K97717496	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.15664
KPNRTBM1	CCLE Cell Line Gene CNV Profiles	-1.0	-1.64238
BRD-K93613839	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.30563
OVCAR8	BioGPS Cell Line Gene Expression Profiles	-1.0	-1.15615
PE(18:1(9Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GSE148692,GSE148695_1_v_3_satb2_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
BRD-K87461415	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.03187
PE(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_3H:A05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.10653
LysoPC(22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN013_HEPG2_24H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.1036
r10 part of basolateral reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.48479
PC(18:3(6Z,9Z,12Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(dm18:1(11Z)/dm16:0)	HMDB Metabolites of Enzymes	1.0	null
OCUG1	DepMap CRISPR Gene Dependency	1.0	7.52333
PC(14:1(9Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K93927229	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.57577
PE(22:1(13Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Arthritis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.1
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
U-2-OS	GDSC Cell Line Gene Expression Profiles	-1.0	-2.25056
PE(15:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A62O-01A-11R-A30C-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(14:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Prostate adenocarcinoma_PRAD_TCGA-HC-7736-01A-11R-2118-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
GSE186767_1_v_0_crizotinib_human	RummaGEO Drug Perturbation Signatures	-1.0	null
PE(20:3(5Z,8Z,11Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
GSE133070_2_v_4_prss1_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
MHH-NB-11	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.928367
RARA_01_51	KnockTF Gene Expression Profiles with Transcription Factor Perturbations	1.0	4.02554
PC(22:4(7Z,10Z,13Z,16Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
SIMA	CCLE Cell Line Gene CNV Profiles	-1.0	-1.75691
PE(18:2(9Z,12Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
KMS-12-BM	COSMIC Cell Line Gene Mutation Profiles	1.0	null
SNB19	BioGPS Cell Line Gene Expression Profiles	-1.0	-1.08445
H3K4me3_megakaryocyte_mm9_1	ENCODE Histone Modification Site Profiles	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-16:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-3657	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.0155
CRCGN017_MCF10A.TP53.M_24H:K20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.50584
internal male genital organ	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.13498
abnormal heart morphology	IMPC Knockout Mouse Phenotypes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
Minor vestibular gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.706
PE(20:1(11Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PMC9894241-pnas.2211429119.sd05.xlsx-G6_REST-Dataset_S6_Differentially_expressed_genes_in_G1-G8_REST	Rummagene Transcription Factor Associations 2026	1.0	null
PE(22:2(13Z,16Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
SK-MEL-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.864412
PE(18:2(9Z,12Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GOTO	GDSC Cell Line Gene Expression Profiles	-1.0	-1.60805
PE(14:1(9Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K02420839	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.41712
PC(18:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K11227160	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.32962
PE(18:3(9Z,12Z,15Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN011_HEPG2_24H:G13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.4662
mantle zone of CbH	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.96844
lateral part of r9B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.52942
Heart	BioGPS Human Cell Type and Tissue Gene Expression Profiles	1.0	1.46229
iif	GeneRIF Biological Term Annotations	1.0	null
PE(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
abnormal testis morphology	IMPC Knockout Mouse Phenotypes	1.0	null
cerebellar cortex_2 yrs_F_12979	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.31774
FOXH1-21741376-ESCS-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PE(20:2(11Z,14Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
YMB-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.44227
PE(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-24	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.880544
BRD-K75961186	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.36794
Crus 1	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.09504
PE(24:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-55-8204-01A-11R-2241-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PMC10154349-41418_2023_1142_MOESM6_ESM.xlsx-Sheet1-Supplementary_data_3_Genes_positively_correlated_with_HOXC13-AS_in_skin_granular_cells_correlation_coefficients_cor_0_FDR_0_05_HOXC13	Rummagene Transcription Factor Associations 2026	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
T3M4	BioGPS Cell Line Gene Expression Profiles	1.0	0.853358
hsa-miR-4755-3p	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.843347
PE(16:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
SK-CO-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.64131
PE(18:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
HCC70	CCLE Cell Line Gene CNV Profiles	1.0	1.6952
CLOCK	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	16.0895
metabolism	GAD Gene-Disease Associations	1.0	null
posterior triangular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.16528
Bladder Urothelial Carcinoma_BLCA_TCGA-2F-A9KQ-01A-11R-A38B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
ONDA9	DepMap CRISPR Gene Dependency	1.0	3.59183
vegf signaling pathway	KEGG Pathways	1.0	null
CRCGN014_HEPG2_24H:K05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.58369
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
Perturb_13017_KO_ALOX5_SRP367905	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	-3.19157
PE(18:2(9Z,12Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
1-Acyl-sn-glycero-3-phosphocholine	MW Enzyme Metabolite Associations	1.0	null
eGFP-FOS_K562_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PC(18:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
pcgf2_17452456_medulloblastoma_lof_human_gpl570_gds2724	GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations	1.0	0.159644
PC(18:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PLCG2	Hub Proteins Protein-Protein Interactions	1.0	null
SNAI1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	27.5865
PC(18:1(11Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
SK-MEL-31	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.862994
PC(18:3(6Z,9Z,12Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.TP53.M_24H:C07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.8147
r3 part of dorsal cochlear nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.50674
CRCGN008_HEPG2_24H:K02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.6444
Skin Cutaneous Melanoma_SKCM_TCGA-EB-A5SF-01A-11R-A311-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
MAPK3	Hub Proteins Protein-Protein Interactions	1.0	null
phosphatidylglycerol acyl-chain remodeling	GO Biological Process Annotations 2023	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-CV-7425-11A-01R-2081-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Perturb_3821_KO_Zfp280c_SRP330880	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	-1.0	-3.48098
PE(20:1(11Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
STAT5A-24692510-EPITHELIUM-MOUSE-MAMMARY	ChEA Transcription Factor Targets 2022	1.0	null
extracellular region	LOCATE Predicted Protein Localization Annotations	1.0	null
CRCGN015_MCF10A_48H:H24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.13339
CRCGN015_MCF10A_48H:L04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.01297
SUM 229PE	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.01554
Early endosome membrane	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.585
PE(14:1(9Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
r4 part of dorsal cochlear nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.21677
BRD-K16641781	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.0661
gastrointestinal tract	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.056493
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN011_HEPG2_24H:P03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.2338
CRCGN010_HEPG2_24H:C20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.00021
PC(P-16:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K94014921	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.0564
PC(15:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
r4 part of posteroventral cochlear nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.35103
BRD-K39794286	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.0533
Amylin receptor complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.883
CRCGN017_MCF10A.TP53.M_24H:P21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.52709
PE(18:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-CV-7427-01A-11R-2081-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
periventricular stratum of r3Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.50622
PC(22:4(7Z,10Z,13Z,16Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
testis	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	-1.0	-0.937652
PE(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
mediodorsal nucleus of thalamus_40 yrs_F_12304	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-2.19254
PE(24:1(15Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
alpha-Linolenic acid	MW Enzyme Metabolite Associations	1.0	null
primary auditory cortex (core)_36 yrs_M_12302	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.0073
PC(P-18:1(9Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
mantle zone of r7BM	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.75075
PC(P-18:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
H2AFZ	ENCODE Transcription Factor Targets	1.0	null
PC(20:3(5Z,8Z,11Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
negative regulation of T cell proliferation	GO Biological Process Annotations 2023	1.0	null
cellular process	GO Biological Process Annotations 2015	1.0	null
PE(18:3(6Z,9Z,12Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
Glycerophospholipid metabolism	KEGG Pathways 2026	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE94849_6_v_0_pinometostat_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(18:2(9Z,12Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
urogenital system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.062329
Perturb_13681_KD_ATG5_ERP127841	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	4.99404
BRD-K10092312	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.26777
PE(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
male reproductive gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.104144
cell part	LOCATE Curated Protein Localization Annotations	1.0	null
hsa-miR-4707-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.07142
CRCGN008_HEPG2_24H:C20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.04005
GSE138815,GSE138817_3_v_1_kdm6a_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PE(24:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K87205390	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.01603
PE(18:3(6Z,9Z,12Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
H3K27me3_Chondrocytes from Bone Marrow Derived Mesenchymal Stem Cell Cultured Cells	Roadmap Epigenomics Histone Modification Site Profiles	1.0	null
trunk	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
C32TG	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.11844
BRD-K32277249	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.38393
PE(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
U138	BioGPS Cell Line Gene Expression Profiles	-1.0	-1.36536
PC(18:4(6Z,9Z,12Z,15Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.WT.HP_24H:N14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.8205
PC(20:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.WT.HP_24H:C24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.46379
CRCGN011_HEPG2_24H:G15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.21165
r9 part of basointermediate reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.594
CRCGN008_HEPG2_24H:H03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.19305
PE(20:4(8Z,11Z,14Z,17Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PMC8724844-bt-30-1-98-supple2.xlsx-GO_BP-SP1_SP1	Rummagene Transcription Factor Associations 2026	1.0	null
BRD-K50884475	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.13999
OCUB-M	COSMIC Cell Line Gene Mutation Profiles	1.0	null
whole body	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.055552
small molecule metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(18:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
GSE176008_7_v_3_azacitidine_human	RummaGEO Drug Perturbation Signatures	-1.0	null
PC(o-22:1(13Z)/22:3(10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
embryonic structure	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.053081
Acyl chain remodelling of PE	Reactome Pathways 2024	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN008_HEPG2_24H:O05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.93935
PMC11426526-ppat.1012555.s014.xlsx-DEG_DC_C91-PL_LPS_vs_DC_Jurkat-Unnamed_5_IRF6	Rummagene Transcription Factor Associations 2026	1.0	null
PC(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
RBP2_deficiency_GDS2731_62_mouse_embryonic fibroblasts	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
basal plate of p1	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.15832
Crus 2	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.49531
phosphate-containing compound metabolic process	GO Biological Process Annotations 2023	1.0	null
hematopoietic cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.055371
ZNF784	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	23.0712
BRD-K87815532	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.12863
PE(22:1(13Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
15930337-TableS4	GeneSigDB Published Gene Signatures	1.0	null
ETV1-20927104-GIST48-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(dm18:0/dm18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE161302,GSE161304_1_v_0_enzalutamide_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.3097
PC(18:2(9Z,12Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K77634878	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.04345
BRD-K16988512	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.15582
PC(18:3(9Z,12Z,15Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A_48H:M16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.77145
BRD-K76755163	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.08478
blood vessel	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.07923
BRD-K46936109	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.2444
SLR25	CCLE Cell Line Gene Expression Profiles	1.0	1.6543
PC(24:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
MEWO	CCLE Cell Line Gene CNV Profiles	1.0	1.54405
PE(18:3(9Z,12Z,15Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-449b	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.0155
496100473_TCx_possible Alzheimer's disease_TBI_89_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	3.13547
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
prdm1_00000000_e9dot5_placenta_lof_mouse_gpl6887_gse39584	GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations	1.0	0.073787
PE(14:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
VEZF1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	63.5433
CRCGN017_MCF10A.TP53.M_24H:K23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.4561
PE(22:1(13Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Hair follicle outer root sheath	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.223
BRD-K82105033	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.41392
PC(24:1(15Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-VS-A8EL-01A-11R-A37O-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CRCGN017_MCF10A.WT.HP_24H:K22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.7974
PC(22:2(13Z,16Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
intestine	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.059779
PE(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
primary metabolic process	GO Biological Process Annotations 2015	1.0	null
PC(16:1(9Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE223287,GSE223290_2_v_4_braf_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
HDAC2	ENCODE Transcription Factor Targets	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PMC12381255-41389_2025_576_MOESM3_ESM.xlsx-Differentiated_SRCAP-1879-Gene_SRCAP	Rummagene Transcription Factor Associations 2026	1.0	null
CRCGN017_MCF10A.TP53.M_24H:K03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.20701
PE(18:3(6Z,9Z,12Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(dm18:0/dm18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Kidney renal papillary cell carcinoma_KIRP_TCGA-J7-A8I2-01A-12R-A36F-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(20:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Pheochromocytoma and Paraganglioma_PCPG_TCGA-QR-A706-01A-11R-A35K-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
LB996-RCC	GDSC Cell Line Gene Expression Profiles	-1.0	-1.42386
DETROIT 562	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.976666
CRCGN013_HEPG2_24H:O04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.78969
PE(24:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-F7-A50G-01A-11R-A266-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
alpha-Linolenic acid metabolism	KEGG Pathways 2026	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:G23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.21294
PE(20:4(5Z,8Z,11Z,14Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K68056389	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.38108
SMIM20	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.05504
anterior (rostral) cingulate (medial prefrontal) cortex_8 yrs_M_12841	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.25948
TFEB	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	34.3668
PE(14:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
Pheochromocytoma and Paraganglioma_PCPG_TCGA-QR-A703-01A-11R-A35K-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K08154407	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.06851
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma_DLBC_TCGA-VB-A8QN-01A-11R-A38C-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
inferolateral temporal cortex (area TEv, area 20)_2 yrs_F_12979	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.06029
organism form	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.052521
496100472_PCx_possible Alzheimer's disease_TBI_100+_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	5.41836
Acyl chain remodelling of PC	Reactome Pathways 2024	1.0	null
PC(16:1(9Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Thorax	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
phosphatidylserine acyl-chain remodeling	GO Biological Process Annotations 2025	1.0	null
PE(22:2(13Z,16Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
anterior (rostral) cingulate (medial prefrontal) cortex_8 pcw_M_13058	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-0.897191
Lung Diseases	HuGE Navigator Gene-Phenotype Associations	1.0	null
BRD-K39396484	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.10319
GATA4	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	17.5143
PC(22:2(13Z,16Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Kidney Chromophobe_KICH_TCGA-KO-8415-11A-01R-2315-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
H3K4me3_G1E-ER4_mm9_1	ENCODE Histone Modification Site Profiles	1.0	null
PC(18:3(9Z,12Z,15Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
experimental	GeneRIF Biological Term Annotations	1.0	null
PE(14:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
REH	CCLE Cell Line Gene Expression Profiles	1.0	1.50128
PPARA::RXRA	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	25.9307
Synthesis of PA	Reactome Pathways 2024	1.0	null
Prostate adenocarcinoma_PRAD_TCGA-J4-A83I-01A-11R-A36G-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K83481256	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.07103
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE145215_0_v_3_krt13_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K48717228	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.46809
GSE164494_1_v_2_rab22a_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
Acyl chain remodelling of PI	Reactome Pathways 2014	1.0	null
mediodorsal nucleus of thalamus_36 yrs_M_12302	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.07853
CRCGN010_HEPG2_24H:G16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.71933
intermediate stratum of r9Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.15066
COLO201	CCLE Cell Line Gene Expression Profiles	1.0	2.26049
Asthma	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.089
PE(18:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K09137343	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.05358
PE(18:3(9Z,12Z,15Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Gland	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
HCC366	CCLE Cell Line Gene Expression Profiles	-1.0	-1.4768
striatum_40 yrs_F_12304	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.39288
CRCGN012_HEPG2_24H:O05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.83886
BT474	CCLE Cell Line Gene Expression Profiles	-1.0	-2.03044
PE(18:4(6Z,9Z,12Z,15Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H1048	COSMIC Cell Line Gene Mutation Profiles	1.0	null
CRCGN015_HEPG2_48H:L01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.75926
PC(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(o-20:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Adrenocortical carcinoma_ACC_TCGA-OR-A5LG-01A-11R-A29S-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K82868643	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.02659
1-Radyl-2-acyl-sn-glycero-3-phosphocholine	MW Enzyme Metabolite Associations	1.0	null
ZXDC1_KD_GSE45417_686_human_U937	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
PC(o-22:2(13Z,16Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-P5-A5F1-01A-11R-A28M-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
microphthalmia	IMPC Knockout Mouse Phenotypes	1.0	null
Prdm14	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	16.3998
PC(P-18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
superficial stratum of m1AL	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.59042
BRD-K35861449	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.23471
BRD-K22944782	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.61218
PC(18:4(6Z,9Z,12Z,15Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GSE221077_1_v_0_sirt6_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
Liver hepatocellular carcinoma_LIHC_TCGA-2Y-A9GT-01A-11R-A38B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BEN	CCLE Cell Line Gene Expression Profiles	-1.0	-1.88457
PC(20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
plasma cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.426872
PE(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
Perturb_13021_KO_ALOX5_SRP367905	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	-2.05028
PC(14:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
m2 part of paranigral nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.11651
midgut	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.160964
PE(15:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K89853033	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.55161
PC(18:1(9Z)/18:1(9Z)) 	HMDB Metabolites of Enzymes	1.0	null
SNU216	DepMap CRISPR Gene Dependency	1.0	2.00316
increased grip strength	MGI Mouse Phenotype Associations 2023	1.0	null
BRD-K18822985	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.24266
GSE88819_0_v_8_tug1_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
TP53	ChEA Transcription Factor Targets	1.0	null
PE(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GSE248935_1_v_0_cd14_human	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CHAGOK1	CCLE Cell Line Gene CNV Profiles	1.0	2.15436
phagocyte	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.086236
Posterolateral visual area, layer 2/3	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.1528
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-HM-A3JJ-01A-21R-A21T-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
ZNF92	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.91346
PC(22:4(7Z,10Z,13Z,16Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.TP53.M_24H:M04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.98025
intermediate stratum of r7BI	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.67655
PE(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
EZH2_H1-hESC_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PE(18:3(9Z,12Z,15Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
seminal vesicle	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.650966
PE(16:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Pparg::Rxra	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	34.7953
JAK2_mutant_40_GSE11003	GEO Signatures of Differentially Expressed Genes for Kinase Perturbations	-1.0	-2.00439
extracellular region	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.663342
PC(P-18:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
RT11284	CCLE Cell Line Gene Expression Profiles	1.0	2.04557
CRCGN009_HEPG2_24H:O04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.23771
LMO2-26923725-CHIP-SEQ-MACROPHAGESS-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PE(16:1(9Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
HGC-27	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.1239
Head and Neck squamous cell carcinoma_HNSC_TCGA-BB-7863-01A-11R-2232-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
MAX_HepG2_hg19_3	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PE(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
NCI-H2073	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.845956
hsa-miR-664	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.880544
r7 part of paragigantocellular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.33341
PC(22:4(7Z,10Z,13Z,16Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
ion binding	GO Molecular Function Annotations 2015	1.0	null
PE(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
FIGLA	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	31.6806
PC(20:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
Declive (VI), granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.51772
Rectum adenocarcinoma_READ_TCGA-DT-5265-01A-21R-1830-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(16:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidylcholine metabolic process	GO Biological Process Annotations 2015	1.0	null
PC(15:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PMC5352183-oncotarget-08-624-s009.xlsx-Table_S20-1_indicates_that_the_gene_is_both_a_TP53-MW_and_a_TP53-MSN_gene_in_the_correponding_cancer_and_0_indicates_not_TP53	Rummagene Transcription Factor Associations 2026	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE216043_7_v_2_cisplatin_human	RummaGEO Drug Perturbation Signatures	1.0	null
PE(20:1(11Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-DU-A7TA-01A-11R-A33Z-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
periventricular stratum of r4Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.03517
PC(dm18:1(11Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
USF2	JASPAR Predicted Transcription Factor Targets	1.0	null
PE(14:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K83012560	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.64385
K562	BioGPS Cell Line Gene Expression Profiles	1.0	1.0976
phospholipid biosynthetic process	GO Biological Process Annotations 2015	1.0	null
ATOH7	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	23.9457
PC(o-14:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:D05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.14725
PC(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
SNU-5	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.98272
Brain - Cerebellar Hemisphere	GTEx Tissue Gene Expression Profiles 2023	1.0	5.31476
H3K27me3_Bone Marrow Derived Mesenchymal Stem Cell Cultured Cells	Roadmap Epigenomics Histone Modification Site Profiles	1.0	null
CRCGN017_MCF10A.TP53.M_24H:P24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.00324
PC(20:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K55940699	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.77959
GSE202825_2_v_1_ano1_human	RummaGEO Gene Perturbation Signatures	1.0	null
PC(22:1(13Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
HCC1171	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.08065
HH	CCLE Cell Line Gene CNV Profiles	1.0	1.5576
macrophage foam cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.35557
molecular layer of CbHCx	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.05289
PC(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-MT-A67F-01A-11R-A30B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:1(11Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
low-density lipoprotein particle	COMPARTMENTS Text-mining Protein Localization Evidence Scores	1.0	0.168101
PC(16:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K88070218	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.02127
extracellular region	LOCATE Curated Protein Localization Annotations	1.0	null
BRD-K38046923	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.31064
PE(14:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
female reproductive system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.062816
BRD-K85909950	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.14972
PMC5894239-12864_2018_4591_MOESM9_ESM.xlsx-ST12_mir_downregulated-Gene_name_KLF6	Rummagene Transcription Factor Associations 2026	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A_48H:P13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.33196
CEP20	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.04624
PC(20:2(11Z,14Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
NEUROG2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	62.71
GSE146074_6_v_8_ly6e_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(18:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:O13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.46285
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-JX-A5QV-01A-22R-A28H-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CRCGN014_HEPG2_24H:F22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.33365
BRD-K88988134	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.81721
PE(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K15794956	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.59323
PC(o-16:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K47849061	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.14418
Folium-tuber vermis (VII)	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.30251
PC(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K37527074	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.43218
PE(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
r6 basal plate	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.54428
PC(20:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
COX6B2	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.92905
PE(18:3(9Z,12Z,15Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN009_HEPG2_24H:K01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.45303
PE(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Flocculus, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.84041
SNU1214	CCLE Cell Line Gene Expression Profiles	-1.0	-1.64766
CRCGN016_MCF10A.WT.HP_24H:F05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.90358
CAMA1	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	-1.0	-1.08049
capillary endothelial cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.795208
perturbation	GeneRIF Biological Term Annotations	1.0	null
PE(20:3(8Z,11Z,14Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:H01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.75999
PC(22:1(13Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Ras signaling	WikiPathways Pathways 2024	1.0	null
Pedunculopontine nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.00992
PC(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
RERFGC1B	CCLE Cell Line Gene Expression Profiles	-1.0	-1.82573
PC(22:4(7Z,10Z,13Z,16Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PMC9534852-41598_2022_20572_MOESM4_ESM.xlsx-Sheet1-Supplementary_Table_S4_Transcriptomic_data_related_to_AHR_function_considered_for_metabolic_reconstruction_model_generation_AHR	Rummagene Transcription Factor Associations 2026	1.0	null
LAMA2_Deficiency_GDS1778_747_mouse_Diaphragm (from dystrophia muscularis -dy/dy- mouse model)	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
heart	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
biosynthetic process	GO Biological Process Annotations 2015	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GSE125014_6_v_5_enzalutamide_human	RummaGEO Drug Perturbation Signatures	1.0	null
lipid catabolic process	GO Biological Process Annotations 2015	1.0	null
Acyl chain remodelling of PE	Reactome Pathways 2014	1.0	null
BRD-K54979104	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.68352
PC(18:3(6Z,9Z,12Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.WT.HP_24H:B10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.7919
FXR	MotifMap Predicted Transcription Factor Targets	1.0	null
Atherosclerosis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.317
PC(18:3(6Z,9Z,12Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
periventricular stratum of r3Ve	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.42826
disease	GWASdb SNP-Disease Associations	1.0	0.024765
Head and Neck squamous cell carcinoma_HNSC_TCGA-C9-A47Z-01A-11R-A24H-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
r6 part of ventral parvicellular reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.15692
SW780	CCLE Cell Line Gene Expression Profiles	1.0	2.14025
lymphoid tissue	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.053337
MDAMB175VII	CCLE Cell Line Gene Expression Profiles	1.0	2.38895
CRCGN015_MCF10A_48H:H23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.04178
Prostate adenocarcinoma_PRAD_TCGA-G9-6494-01A-11R-1789-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Gli1	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	20.4731
PE(20:3(8Z,11Z,14Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Skin Cutaneous Melanoma_SKCM_TCGA-ER-A196-01A-11R-A18T-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
VWA1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.74649
Head and Neck squamous cell carcinoma_HNSC_TCGA-CQ-A4CE-01A-11R-A266-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
alcohol metabolic process	GO Biological Process Annotations 2015	1.0	null
GSE235066_4_v_3_cisplatin_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(20:3(8Z,11Z,14Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE181959_1_v_2_dextran_mouse	RummaGEO Drug Perturbation Signatures	-1.0	null
lateral part of r10B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.48377
BRD-A98888138	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.48201
Primary visual area, layer 1	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.01985
PC(18:1(11Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Tcf12	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	32.0688
PC(18:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K87073572	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.77796
PC(24:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
ME-1	COSMIC Cell Line Gene Mutation Profiles	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K81665173	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.79789
PC(16:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Acyl chain remodelling of PG	Reactome Pathways 2014	1.0	null
PE(24:1(15Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PMC10273062-JCMM-27-1708-s001.xlsx-Sheet_1-CESC_AND_UCEC_NOT_BRCA_NOT_UCS_NR4A2	Rummagene Transcription Factor Associations 2026	1.0	null
organonitrogen compound metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(18:1(9Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K25791914	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.14435
PC(20:1(11Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
medial part of r6B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.95205
PC(P-16:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K58232861	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.22155
PE(18:3(6Z,9Z,12Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
interleukin-3 receptor complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	1.134
PC(P-18:1(11Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.TP53.M_24H:H08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.7179
Hemispheric regions	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.0063
GSE88819_3_v_4_tug1_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Pancreatic adenocarcinoma_PAAD_TCGA-HV-A7OL-01A-11R-A33R-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PMC11615365-41467_2024_54246_MOESM4_ESM.xlsx-RT4-Numb-KD_vs_Ctr-KD-ensemblGeneId_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PE(22:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidylcholine metabolic process	GO Biological Process Annotations 2023	1.0	null
PC(18:1(11Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
cerebellar hemisphere	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.96914
PE(20:1(11Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
NACC1-18358816-MESC-mouse	ChEA Transcription Factor Binding Site Profiles	1.0	null
periventricular stratum of cerebellar vermis	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.21848
PC(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
TEF-1	MotifMap Predicted Transcription Factor Targets	1.0	null
hsa-miR-4695-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.7397
PE(20:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
linoleic acid metabolism	KEGG Pathways	1.0	null
PC(14:1(9Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-55-6980-01A-11R-1949-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(16:1(9Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
Disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.568
Neurod2	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	53.452
BRD-K08903301	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.87542
Integumentary system cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.536
Lung squamous cell carcinoma_LUSC_TCGA-NK-A5CT-01A-31R-A26W-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
phospholipase activity	GO Molecular Function Annotations 2023	1.0	null
BRD-K69077676	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.02181
PC(14:1(9Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
alpha linolenic acid metabolism	KEGG Pathways	1.0	null
Omasum	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.545
BRD-K03214579	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.20884
BRD-K86584551	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.67197
HSFX3	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.47124
PE(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
animal	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
CRCGN015_HEPG2_48H:O11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.23235
PC(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
HS939T	CCLE Cell Line Gene Expression Profiles	-1.0	-1.53482
BRD-K18621941	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.0985
CRCGN008_HEPG2_24H:G16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.4372
PC(22:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:B10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.65166
PC(18:2(9Z,12Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
SK-MEL-28	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.964822
FOXO3-23340844-DLD1-HUMAN	ChEA Transcription Factor Binding Site Profiles	1.0	null
PC(22:1(13Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
SNU449	DepMap CRISPR Gene Dependency	1.0	2.43588
r9 part of the basolateral reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-2.05408
FOXO3-23340844-DLD1-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-E1-A7YJ-01A-11R-A34F-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
glycerophospholipid metabolic process	GO Biological Process Annotations 2025	1.0	null
bone marrow cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.249329
PE(18:1(11Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE216043_10_v_2_cisplatin_human	RummaGEO Drug Perturbation Signatures	1.0	null
A431	GDSC Cell Line Gene Expression Profiles	1.0	1.99059
CRCGN015_HEPG2_48H:G15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.31836
NCI-H2198	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.03698
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K05902089	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.23879
cetuximab_homo sapiens_gpl570_gse21483	GEO Signatures of Differentially Expressed Genes for Small Molecules	1.0	null
PE(20:1(11Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
DCA_UP.V1	MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations	1.0	null
primary somatosensory cortex (area S1, areas 3,1,2)_8 yrs_M_12841	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.89361
organophosphate metabolic process	GO Biological Process Annotations 2015	1.0	null
Perturb_9603_KO_Satb2_SRP328167	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	-1.0	-20.0
carboxylic ester hydrolase activity	GO Molecular Function Annotations 2025	1.0	null
PE(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
RBBP5	ENCODE Transcription Factor Targets	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:J22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.2479
mediodorsal nucleus of thalamus_13 yrs_F_12831	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.84608
SAP30_K562_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
TC205	DepMap CRISPR Gene Dependency	1.0	2.02077
PC(20:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Lung	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
CDY1	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.61273
PC(20:4(5Z,8Z,11Z,14Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
thorax	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
PMC10115638-41591_2023_2255_MOESM4_ESM.xlsx-CNS_NB_FOXR2_deletions-Unnamed_2_FOXR2	Rummagene Transcription Factor Associations 2026	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K15607890	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.05711
BRD-K83898323	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.31591
SNU-C1	COSMIC Cell Line Gene Mutation Profiles	1.0	null
PC(22:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
H3K4me1_keratinocyte_hg19_1	ENCODE Histone Modification Site Profiles	1.0	null
CRCGN009_HEPG2_24H:H03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.65602
foam cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.624658
PC(20:2(11Z,14Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
LOX-IMVI	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.25314
PMC8987207-DataSheet_1.xls-TF_targets_Fig_2A-EGR1_DC_ChIP-seq_EGR1	Rummagene Transcription Factor Associations 2026	1.0	null
PE(18:1(9Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
rostral interpeduncular nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.265
PE(20:3(8Z,11Z,14Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K78789413	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.23665
PC(16:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:F17	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.13589
CRCGN014_HEPG2_24H:D13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.54694
PE(22:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
GLIS1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	39.1624
PC(o-18:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
LysoPC(14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
microphthalmia	MGI Mouse Phenotype Associations 2023	1.0	null
PE(20:1(11Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
spinalcordlower	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	-1.0	-1.44088
MDAMB175VII	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	1.0	1.81623
PE(22:2(13Z,16Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
GLI3	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	35.4636
SK-LU-1	GDSC Cell Line Gene Expression Profiles	1.0	1.56279
PMC3009535__F3	PFOCR Pathway Figure Associations 2023	1.0	null
EBF3	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	31.182
primary auditory cortex (core)_1 yrs_F_12830	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.70421
stratum	GeneRIF Biological Term Annotations	1.0	null
CCRF-CEM	GDSC Cell Line Gene Expression Profiles	1.0	1.50721
PE(20:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN009_HEPG2_24H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.74648
LysoPC(18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
SNU-1040	COSMIC Cell Line Gene Mutation Profiles	1.0	null
SYNCRIP_OE_GDS1886_83_human_THP-1 cells	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	null
PC(o-22:1(13Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K60484506	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.38159
Head and Neck squamous cell carcinoma_HNSC_TCGA-BA-A6DJ-01A-11R-A30B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
ZNF528	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	30.586
PC(16:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
GATA2	JASPAR Predicted Transcription Factor Targets	1.0	null
PE(18:2(9Z,12Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K69699301	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.0992
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K96295480	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.9599
CRCGN017_MCF10A.TP53.M_24H:H24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.91617
Bladder Urothelial Carcinoma_BLCA_TCGA-CU-A3YL-01A-11R-A22U-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(16:1(9Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
GSE160817_2_v_8_slamf6_human	RummaGEO Gene Perturbation Signatures	1.0	null
PC(20:1(11Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
Metabolism of lipids and lipoproteins	Reactome Pathways 2014	1.0	null
PE(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
metal ion binding	GO Molecular Function Annotations 2023	1.0	null
Acyl chain remodelling of PS	Reactome Pathways 2024	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN008_HEPG2_24H:O03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.0418
PC(o-18:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:G05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	8.03273
PE(15:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K08406395	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.56812
Bone inflammation disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.093
mantle zone of cerebellar vermis	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.2455
ventrolateral prefrontal cortex_3 yrs_F_12836	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.11375
PE(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:J15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.58125
CRCGN016_MCF10A.TP53.M_24H:K05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	9.1251
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
liminal reticular formation of m2	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.88977
Myristic acid	HMDB Metabolites of Enzymes	1.0	null
Posterolateral visual area, layer 4	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.16285
BRD-A39900448	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.22345
isthmus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.05772
superficial stratum of r2Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.31773
CRCGN014_HEPG2_24H:D07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.184
PC(24:1(15Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
MYOD1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	31.935
PC(16:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(20:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K81288338	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.16518
PE(24:1(15Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K33371292	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.64273
496100395_TCx_no dementia_no TBI_90-94_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	4.03899
PE(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
Phospholipid metabolism	Reactome Pathways 2014	1.0	null
PC(24:1(15Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K55835264	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.45073
PC(20:4(8Z,11Z,14Z,17Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
ZNF217	ENCODE Transcription Factor Targets	1.0	null
PE(14:1(9Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
MCF7	DepMap CRISPR Gene Dependency	1.0	2.10374
PE(18:1(11Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-73-4658-01A-01R-1755-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
skeletal system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.054597
PE(20:3(8Z,11Z,14Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-1233	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
PC(24:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN013_HEPG2_24H:O01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.97859
PE(18:2(9Z,12Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
HCC1395	GDSC Cell Line Gene Expression Profiles	-1.0	-1.56016
CRCGN015_HEPG2_48H:L19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.5382
BRD-K09523238	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.28538
Spleen	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
Pheochromocytoma and Paraganglioma_PCPG_TCGA-W2-A7HC-01A-11R-A35L-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K89260735	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.75031
BRD-K20348534	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.56321
superficial stratum of r3Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.12343
PC(P-18:1(9Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-MT-A67A-01A-11R-A30B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
ZR7530	CCLE Cell Line Gene CNV Profiles	-1.0	-1.38871
CRCGN015_HEPG2_48H:F01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.2704
PC(15:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidic acid biosynthetic process	GO Biological Process Annotations 2015	1.0	null
PC(18:2(9Z,12Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Acute Myeloid Leukemia_LAML_TCGA-AB-2978-03A-01T-0734-13	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Upper epidermis	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.692
hindbrain	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.02201
PC(22:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K56424158	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.60891
Lamellar body	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	1.264
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
gonad	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.169017
PE(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K55623459	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.42834
PE(20:2(11Z,14Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
MDAMB453	DepMap CRISPR Gene Dependency	1.0	2.28664
BRD-K47804666	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.12135
WSUDLCL2	CCLE Cell Line Gene Expression Profiles	1.0	1.6043
alitretinoin_homo sapiens_gpl6480_gse43090	GEO Signatures of Differentially Expressed Genes for Small Molecules	1.0	null
PE(18:3(6Z,9Z,12Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
GSE104022_3_v_7_tamoxifen_mouse	RummaGEO Drug Perturbation Signatures	1.0	null
PC(o-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
Pyramus (VIII), molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.21883
FAM72A	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.86597
PC(18:3(9Z,12Z,15Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.WT.HP_24H:F16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.15705
PC(20:4(8Z,11Z,14Z,17Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN010_HEPG2_24H:O04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.10322
Paramedian lobule	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.06608
A172	BioGPS Cell Line Gene Expression Profiles	-1.0	-0.962122
PE(22:5(7Z,10Z,13Z,16Z,19Z)/dm18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Uvula (IX), granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.07683
PC(18:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K84143716	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.52651
Pityriasis rubra pilaris	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.631
HDAC2_K562_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
single-organism process	GO Biological Process Annotations 2015	1.0	null
BRD-K50961262	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.4294
NCIH1563	CCLE Cell Line Gene CNV Profiles	-1.0	-1.51297
Alopecia	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.558
PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
HCC1143	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	1.0	0.667942
PC(18:3(6Z,9Z,12Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
LIN28A_01_215	KnockTF Gene Expression Profiles with Transcription Factor Perturbations	1.0	3.27439
PC(20:3(8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GM97	BioGPS Cell Line Gene Expression Profiles	1.0	1.43197
PE(16:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
MAPK1	Hub Proteins Protein-Protein Interactions	1.0	null
Stat4	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	20.5896
BRD-K43435656	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.90964
BRD-K86228587	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.94907
PE(16:1(9Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
H3K9me3_NT2-D1_hg19_1	ENCODE Histone Modification Site Profiles	1.0	null
PE(24:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
periventricular stratum of r2Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.14688
PC(24:1(15Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Glycerophospholipid biosynthesis	Reactome Pathways 2024	1.0	null
PE(16:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:2(9Z,12Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
Twist2	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	17.8894
Head and Neck squamous cell carcinoma_HNSC_TCGA-CV-A6JT-01A-11R-A31N-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(24:1(15Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K81363924	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.34727
PE(20:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
orbital frontal cortex_21 yrs_F_13057	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.857187
BRD-K07802542	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.14439
Disease of cellular proliferation	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.204
PE(24:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Pyramus (VIII), granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.14897
PE(20:1(11Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-F7-A623-01A-11R-A28V-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
ZNF124	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.75582
PC(20:4(5Z,8Z,11Z,14Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Metabolism	Reactome Pathways 2014	1.0	null
PE(15:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.WT.HP_24H:A17	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.98064
PC(15:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
Adrenocortical carcinoma_ACC_TCGA-OR-A5L4-01A-11R-A29S-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K01162126	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.30905
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidylserine metabolic process	GO Biological Process Annotations 2015	1.0	null
BRD-K34703146	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.50512
PE(18:3(9Z,12Z,15Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Musculoskeletal system disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.458
CRCGN009_HEPG2_24H:L07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.6822
PE(22:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K75900952	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.27195
PC(20:3(5Z,8Z,11Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/dm18:0)	HMDB Metabolites of Enzymes	1.0	null
intermediate stratum of r9Tr	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.00343
cSARS Bat SRBD_0Hour_None_GSE37827	GEO Signatures of Differentially Expressed Genes for Viral Infections	1.0	1.20074
CRCGN009_HEPG2_24H:O02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.79166
PE(P-16:0e/16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_3H:J16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	-1.0	-2.04938
Primary T cells from cord blood	Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles	-1.0	-1.26533
intermediate stratum of r10Tr	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.68892
496100539_HIP_probable Alzheimer's disease_TBI_78_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	2.17525
PE(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
phosphatidylglycerol acyl-chain remodeling	GO Biological Process Annotations 2015	1.0	null
PE(14:1(9Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
JHH-5	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.98331
PE(20:4(8Z,11Z,14Z,17Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K27335290	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.13268
HCC1500	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.18897
PE(18:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
Paramedian lobule, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.01234
PC(15:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K19320442	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.10537
Lobule III, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.32772
PC(16:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
lymphoid tissue	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
PE(15:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
SA1-27219007-CHIP-SEQ-BCELLS-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PE(14:1(9Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K11610091	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.28774
primary motor cortex (area M1, area 4)_18 yrs_M_12984	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.12921
BRD-K86050213	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.48352
BRD-K21678546	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.06556
Autoimmune disease of skin and connective tissue	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.793
Perturb_15981_KO_Ewsr1_SRP164692	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	1.0	2.16324
disease of anatomical entity	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.039598
colorectum	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.065792
Purkinje cell layer of CbHCx	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.97553
PC(o-16:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-3909	TargetScan Predicted Conserved microRNA Targets	1.0	0.219115
PMC9253713-mmc3.xls-sufu_KD_HCC1954_DEGs-Unnamed_2_AR	Rummagene Transcription Factor Associations 2026	1.0	null
hsa-miR-3150b-3p	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.99187
PMC11615365-41467_2024_54246_MOESM4_ESM.xlsx-RT4-Numb-KD_vs_Ctr-KD-geneSymbol_AR	Rummagene Transcription Factor Associations 2026	1.0	null
SMS	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.1784
PC(20:3(8Z,11Z,14Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
gnrh signaling pathway	KEGG Pathways	1.0	null
CRCGN013_HEPG2_24H:G15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.87702
Pheochromocytoma and Paraganglioma_PCPG_TCGA-QR-A7IN-01A-11R-A35K-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(16:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K36718717	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.03575
PE(20:3(5Z,8Z,11Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
urinary bladder	HPA Tissue Gene Expression Profiles	1.0	1.00264
PE(18:1(11Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_3H:D03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.08216
LysoPC(20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K09819684	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.89496
PE(22:1(13Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN010_HEPG2_24H:O19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.60727
CRCGN016_MCF10A.TP53.M_24H:P24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.181
primary visual cortex (striate cortex, area V1/17)_21 yrs_F_13057	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.78059
PC(18:1(9Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
HEL9217	CCLE Cell Line Gene CNV Profiles	1.0	1.60506
PC(o-16:1(9Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A_48H:P05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.6358
PC(22:1(13Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CEBPB-20176806-MACROPHAGES-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PMC11551338-pnas.2411189121.sd01.xlsx-FXR-Unnamed_0_NR1H4	Rummagene Transcription Factor Associations 2026	1.0	null
BRD-K19946529	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.35552
BRD-K69751974	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.27019
bmi1_17452456_medulloblastoma_lof_human_gpl570_gds2724	GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations	1.0	0.187594
BRD-K57228212	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.22886
C-33 A	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.04962
PC(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
OCUM1	CCLE Cell Line Gene Expression Profiles	1.0	1.52567
blood	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.054956
Skin Cutaneous Melanoma_SKCM_TCGA-EB-A44N-01A-11R-A266-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Lateral habenula	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.07896
metal ion binding	GO Molecular Function Annotations 2025	1.0	null
SNU182	DepMap CRISPR Gene Dependency	1.0	6.64226
PE(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
leydig cell line	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	1.02075
USF1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	26.5277
KLF4-25985364-ATHEROSCLEROSIS-LESION-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PC(14:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Nutrition disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.049
PE(20:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
HDAC6	ENCODE Transcription Factor Targets	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE208254_4_v_1_irf8_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PE(22:1(13Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
periventricular stratum of r4Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.21711
GSE189653,GSE203344_2_v_0_fluoxetine_mouse	RummaGEO Drug Perturbation Signatures	1.0	null
PC(20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
NB7	DepMap CRISPR Gene Dependency	1.0	5.07194
PC(20:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A_48H:J16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	8.1344
PC(22:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
SAP30	ENCODE Transcription Factor Targets	1.0	null
hsa-miR-3184	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.07142
T47D	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	-1.0	-0.722536
SUP-B8	COSMIC Cell Line Gene Mutation Profiles	1.0	null
CHLA266	DepMap CRISPR Gene Dependency	1.0	3.42256
BRD-K49577636	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.39359
Lobules IV-V	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.47319
H3K4me1_cortical plate_mm9_1	ENCODE Histone Modification Site Profiles	1.0	null
Dentate granule cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.673
PE(20:2(11Z,14Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
KMRC2	CCLE Cell Line Gene CNV Profiles	-1.0	-1.38845
protein-lipid complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores	1.0	0.078645
PE(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
SUM185PE	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	-1.0	-1.10307
CRCGN012_HEPG2_24H:M13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.56479
PC(20:3(8Z,11Z,14Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
connective tissue	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.079381
PE(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
Kidney renal clear cell carcinoma_KIRC_TCGA-CJ-4891-01A-01R-1305-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:1(11Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE148692,GSE148695_1_v_0_satb2_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(14:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
disease of cellular proliferation	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.039553
MSANTD3	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	15.0624
TK-10	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.09478
PC(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
IGR-37	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.864412
PC(24:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Whole body	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
LB2241-RCC	GDSC Cell Line Gene Expression Profiles	-1.0	-1.63253
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-1270	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.965816
RMI2	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.28648
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Dermatitis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.558
BRD-K81608755	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.66369
PC(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
seminiferous tubule	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.395331
Acyl chain remodelling of PI	Reactome Pathways 2024	1.0	null
JHH-6	COSMIC Cell Line Gene Mutation Profiles	1.0	null
BRD-K69453385	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.53052
PC(18:1(9Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
RBBP5_H1-hESC_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PE(16:1(9Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4745-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.0155
mantle zone of p1B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.22394
Enteroendocrine cell_Intestinal crypt_Mouse	CellMarker Gene-Cell Type Associations	1.0	null
ZNF574	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	40.2247
primary somatosensory cortex (area S1, areas 3,1,2)_18 yrs_M_12984	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-0.825502
BRD-K74547048	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.68982
BRD-K28140275	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.31828
PC(18:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
19036130-TableS1a	GeneSigDB Published Gene Signatures	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-FD-A6TC-01A-21R-A33J-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(14:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
Mesothelioma_MESO_TCGA-NQ-A638-01A-11R-A34F-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K13559806	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.71199
GSE232631_5_v_1_brca2_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
Simple lobule	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.87789
single-organism catabolic process	GO Biological Process Annotations 2015	1.0	null
vomeralnasalorgan.VMO.	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	-1.0	-0.874759
Perturb_4484_OE_Msi2_SRP067535	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	1.0	3.34104
PC(18:1(11Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
mantle zone of r2Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.29173
Genetic disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.093
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Liver hepatocellular carcinoma_LIHC_TCGA-ZS-A9CE-01A-11R-A37K-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CRCGN017_MCF10A.WT.HP_24H:A13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.4687
Central lobule	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.1528
PC(24:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
intermediate stratum of r9BI	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.59282
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
MAPK14_knockout_13_GDS2693	GEO Signatures of Differentially Expressed Genes for Kinase Perturbations	-1.0	-1.3161
cerebellum	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	-1.0	-1.12543
GSE180200,GSE180201_3_v_0_qpctl_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PC(24:1(15Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
LysoPC(16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K74694052	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.36875
r2 part of anteroventral cochlear nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.31773
PC(22:1(13Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE174701_1_v_6_maml3_human	RummaGEO Gene Perturbation Signatures	1.0	null
BRD-K07959057	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.61099
PC(18:4(6Z,9Z,12Z,15Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.TP53.M_24H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.63853
PMC7783757__F7	PFOCR Pathway Figure Associations 2023	1.0	null
PE(22:1(13Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
rhombomere 1	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.71876
BRD-A68526335	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.12846
Trunk	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
granulosum	GeneRIF Biological Term Annotations	1.0	null
GSE176008_4_v_1_azacitidine_human	RummaGEO Drug Perturbation Signatures	1.0	null
CRCGN016_MCF10A.WT.HP_24H:P22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.53505
CRCGN015_HEPG2_48H:G06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.61713
H2AFZ_keratinocyte_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
superficial stratum of cerebellar vermis	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.29037
hsa-let-7e	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
GSE168602,GSE168604_2_v_6_selumetinib_human	RummaGEO Drug Perturbation Signatures	1.0	null
BRD-K86330848	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.26934
PE(18:1(11Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
inferolateral temporal cortex (area TEv, area 20)_12 pcw_F_13060	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.03135
PE(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PMC8684775-CTM2-11-e640-s002.xlsx-Sheet1-Table_S3_MAF_file_of_the_CCS_samples_MAF	Rummagene Transcription Factor Associations 2026	1.0	null
PE(14:1(9Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
KLE	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	2.34201
H3K4me3_small intestine_mm9_1	ENCODE Histone Modification Site Profiles	1.0	null
PE(22:2(13Z,16Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Cecum mucosa	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.542
GSE174751_0_v_1_postn_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
Sarcoma_SARC_TCGA-IS-A3KA-01A-11R-A21T-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(P-18:1(9Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
ZR-75-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.44315
CRCGN016_MCF10A.WT.HP_24H:O13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.44617
PC(22:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
hematopoietic system	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
microcellular tegmental nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-2.24354
PE(20:4(8Z,11Z,14Z,17Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(dm16:0/dm16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K97122937	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.85226
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K36575696	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.06551
PE(18:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K81619018	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.11609
superficial stratum of the PBC	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.08916
intermediate part of r7B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.06823
amygdaloid complex_4 yrs_M_12298	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.06175
GSE87412,GSE92423_2_v_1_dnmt3a_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
CRCGN015_HEPG2_48H:K07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.19421
Neuro D	MotifMap Predicted Transcription Factor Targets	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:B11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.89219
PE(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
MXI1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	25.3262
PE(14:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
H3K4me3_megakaryocyte_mm9_2	ENCODE Histone Modification Site Profiles	1.0	null
PE(20:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
CACNG6	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.60152
Caov-3	GDSC Cell Line Gene Expression Profiles	1.0	1.63402
BRD-K09804899	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.08598
PC(22:2(13Z,16Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
abnormal heart morphology	MGI Mouse Phenotype Associations 2023	1.0	null
BRD-K64353626	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.2801
PC(o-18:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
LysoPC(20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Hematopoietic system	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
C3A	CCLE Cell Line Gene CNV Profiles	1.0	2.03564
NCIH1836	CCLE Cell Line Gene CNV Profiles	1.0	2.75846
Arachidonic acid	MW Enzyme Metabolite Associations	1.0	null
CRCGN012_HEPG2_24H:K01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.10323
PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:O03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.37874
G120	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.52033
HNFA-21074721-CACO-2-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(15:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:H15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.2031
PC(20:2(11Z,14Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:D01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.33996
PMC4366019-pone.0116096.s005.xlsx-Primary_positives_NOT_retested-Primary_S6P_positives_NOT_selected_for_retesting_with_the_4_individual_RNAi_used_in_the_intial_screen_NR4A2	Rummagene Transcription Factor Associations 2026	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-DH-A669-01A-12R-A31N-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(o-14:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
H1-7	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.99308
FLI1-26923725-CHIP-SEQ-MACROPHAGESS-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PE(16:1(9Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
intermediate stratum of r6BL	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.58802
GSE175787_13_v_2_rhoc_human	RummaGEO Gene Perturbation Signatures	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-QK-A6II-01A-11R-A31N-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(18:2(9Z,12Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K17339982	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.3154
PC(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
phospholipase A2 activity	GO Molecular Function Annotations 2023	1.0	null
PC(o-16:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
isthmic portion of paranigral nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.07719
CRCGN015_MCF10A_48H:O11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.722
PE(15:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K56761719	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.46375
BRD-K40019775	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.66007
PE(22:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
A704	CCLE Cell Line Gene CNV Profiles	-1.0	-1.50267
PE(16:1(9Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A_48H:C24	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.34839
PE(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K81035073	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.11942
NCI-H209	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-2.28242
BRD-K42453497	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.41115
TFAP4	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	33.3428
PC(14:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K12918607	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.19235
PC(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
icSARS CoV_24Hour_None_GSE37827	GEO Signatures of Differentially Expressed Genes for Viral Infections	1.0	1.56655
PMC11426526-ppat.1012555.s014.xlsx-DEG_DC_C91-PL_LPS_vs_DC_JK_LPS-Unnamed_5_IRF6	Rummagene Transcription Factor Associations 2026	1.0	null
BRD-K37331547	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.59034
PMC9253713-mmc3.xls-sufu_KD_HCC1954_DEGs-Supplementary_Table_2_Differentially_expressed_genes_upon_knockdown_of_SUFU_compared_to_control_in_HCC1954_cells_Related_to_Figure_3_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN017_MCF10A.TP53.M_24H:H08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.10874
ACHN	BioGPS Cell Line Gene Expression Profiles	-1.0	-1.0685
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
r7 part of basomedial reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.20089
LUDLU1	CCLE Cell Line Gene Expression Profiles	-1.0	-1.57017
spleen	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
LXR-22292898-THP-1-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
BT20	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	1.0	1.50087
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
GGA3	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.10859
striatum_16 pcw_M_12837	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.57278
PE(16:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K73792260	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.6807
PC(20:1(11Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
phosphatidylinositol acyl-chain remodeling	GO Biological Process Annotations 2015	1.0	null
PE(20:2(11Z,14Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
HCC-15	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.03698
PC(P-18:1(11Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-A38066207	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.23763
PC(18:1(11Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
phosphorus metabolic process	GO Biological Process Annotations 2015	1.0	null
PC(24:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
olivary pretectal nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.02275
PC(18:1(11Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
single-organism cellular process	GO Biological Process Annotations 2015	1.0	null
negative regulation of T cell proliferation	GO Biological Process Annotations 2025	1.0	null
DSH1	GDSC Cell Line Gene Expression Profiles	1.0	3.32837
PE(18:4(6Z,9Z,12Z,15Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
COMPOUND 12E [PMID: 18605714]	DGIdb Drug Targets 2026	1.0	7.56171
Flocculus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.82625
PE(20:3(8Z,11Z,14Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K98935620	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.63189
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Lymphoid tissue	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
BRD-K87647164	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.03387
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(4Z,7Z,10Z,13Z,16Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
phospholipase activity	GO Molecular Function Annotations 2025	1.0	null
colorectal cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.077717
Liver hepatocellular carcinoma_LIHC_TCGA-K7-AAU7-01A-11R-A38B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(14:1(9Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
G122	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.03978
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
Cochlear nucleus, subpedunclular granular region	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.36459
PC(16:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K16937802	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.81339
PC(P-18:1(9Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:D09	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.58168
PMC9942993-pone.0281645.s002.xlsx-AR-as_adaptive-SYMBOL_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PE(18:0/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K30738175	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.40259
Disease of anatomical entity	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.566
PE(20:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN011_HEPG2_24H:L12	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.69485
PE(22:1(13Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:1(9Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
primary visual cortex (striate cortex, area V1/17)_8 yrs_M_12841	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.82313
PC(24:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CORL279	DepMap CRISPR Gene Dependency	1.0	3.25511
CRCGN015_HEPG2_48H:K09	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.01781
PE(20:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
ZNF594	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.3464
BRD-K83645749	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.35174
Ras signaling pathway	KEGG Pathways 2026	1.0	null
ZMYM4	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.51593
PC(16:1(9Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
SK-MEL-30	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.62501
GSE168602,GSE168604_2_v_1_selumetinib_human	RummaGEO Drug Perturbation Signatures	1.0	null
PC(22:2(13Z,16Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
EP300	ENCODE Transcription Factor Targets	1.0	null
PE(16:1(9Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K00423214	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.62595
PE(14:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
skin disease	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.05035
PE(20:4(8Z,11Z,14Z,17Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Lung squamous cell carcinoma_LUSC_TCGA-22-1017-01A-01R-0692-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
NP5	DepMap CRISPR Gene Dependency	1.0	2.71888
pyrazinamide_mus musculus_gpl6246_gse48027	GEO Signatures of Differentially Expressed Genes for Small Molecules	-1.0	null
PC(o-22:2(13Z,16Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
CAKI2	CCLE Cell Line Gene Expression Profiles	-1.0	-1.84119
GLIS3	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	52.8674
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
phosphatidylserine metabolic process	GO Biological Process Annotations 2025	1.0	null
PC(14:1(9Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
GSE216988,GSE216989_0_v_1_decitabine_human	RummaGEO Drug Perturbation Signatures	1.0	null
H3K9me3_G1E-ER4_mm9_2	ENCODE Histone Modification Site Profiles	1.0	null
BRD-K37486644	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.44272
PE(22:2(13Z,16Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PMC4366019-pone.0116096.s005.xlsx-Primary_positives_NOT_retested-Unnamed_8_NR4A2	Rummagene Transcription Factor Associations 2026	1.0	null
BRD-K06058625	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.28818
PCGF4-22325352-293T-REX-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
CRCGN017_MCF10A.TP53.M_24H:I10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.57515
BRD-K33597325	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.53652
PC(22:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
phenotypic abnormality	GWASdb SNP-Phenotype Associations	1.0	0.028735
PC(24:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
GSE235066_7_v_3_cisplatin_human	RummaGEO Drug Perturbation Signatures	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
Linoleic acid	HMDB Metabolites of Enzymes	1.0	null
PLAGL2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	79.3315
superficial stratum of r4Co	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.35134
CRCGN010_HEPG2_24H:G15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.55476
1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine	MW Enzyme Metabolite Associations	1.0	null
pantothenic-acid	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.04203
Paraflocculus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.77757
hsa-miR-4267	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.13535
calcium-dependent phospholipase A2 activity	GO Molecular Function Annotations 2023	1.0	null
CRCGN015_HEPG2_48H:A14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.33328
LysoPC(18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PMC12616242-can-24-3452_supplementary_table_s2_suppst2.xlsx-Down_bins-Down_bins_loosing_H3K27me3_in_hpMSC-EWSR1_FLI1_FLI1	Rummagene Transcription Factor Associations 2026	1.0	null
PMC5342415__F3	PFOCR Pathway Figure Associations 2023	1.0	null
atherosclerotic plaque	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.181772
PC(24:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
ASCL1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	72.1235
LysoPC(20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
Ichthyosis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.507
PC(P-18:1(9Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.TP53.M_24H:J23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.32
r6 part of ventral gigangocellular reticular area	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-2.30401
capillary	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.214954
BRD-K20203758	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.03064
Skin Cutaneous Melanoma_SKCM_TCGA-EE-A29G-06A-12R-A18T-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K01478290	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.43711
CRCGN013_HEPG2_24H:O03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.62696
cytosol	GO Cellular Component Annotations 2015	1.0	null
PC(14:1(9Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
posterior (caudal) superior temporal cortex (area 22c)_4 yrs_M_12298	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	0.834283
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-BI-A0VS-01A-11R-A10U-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K64451058	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.30505
PC(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K90094729	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.27347
GSE111061_1_v_0_tofacitinib_human	RummaGEO Drug Perturbation Signatures	-1.0	null
mantle zone of PcPD	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.0372
ether lipid metabolism	KEGG Pathways	1.0	null
PC(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-3622b-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.880544
PMC9124206-41419_2022_4940_MOESM8_ESM.xlsx-DEG_PACA-CA-ID_PTF1A	Rummagene Transcription Factor Associations 2026	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
GSE202603_3_v_2_bhlhe40_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
CRCGN015_MCF10A.TP53.M_24H:P21	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.09485
GSE161170,GSE161268_0_v_2_med1_human	RummaGEO Gene Perturbation Signatures	-1.0	null
KDM5A_H1-hESC_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PC(15:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K01096898	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.59845
Stomach Smooth Muscle	Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles	-1.0	-0.857784
Liver hepatocellular carcinoma_LIHC_TCGA-RC-A7SF-01A-11R-A352-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Allergic contact dermatitis	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.295
PC(18:1(11Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN009_HEPG2_24H:L08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.4836
LysoPC(18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE186660_2_v_1_nicotine_mouse	RummaGEO Drug Perturbation Signatures	-1.0	null
BRD-K88080911	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.86794
PC(o-22:1(13Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:2(11Z,14Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
SKBR3	Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles	1.0	0.690229
GSE109285_3_v_2_glucagon_mouse	RummaGEO Drug Perturbation Signatures	1.0	null
HEY1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	38.5184
PE(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
GSE215849_2_v_1_muc1_human	RummaGEO Gene Perturbation Signatures	-1.0	null
PMC8025515-12859_2021_4105_MOESM12_ESM.xlsx-PW1-gene_stable_id_PEG3	Rummagene Transcription Factor Associations 2026	1.0	null
PE(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE160817_4_v_1_slamf6_human	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
localize	GeneRIF Biological Term Annotations	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
496100631_PCx_dementia_TBI_77_M	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	2.66464
PE(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
Arachidic acid	HMDB Metabolites of Enzymes	1.0	null
phosphate-containing compound metabolic process	GO Biological Process Annotations 2015	1.0	null
calcium ion binding	GO Molecular Function Annotations 2015	1.0	null
PE(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K29130550	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.36247
HDAC6_K562_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PC(P-18:1(11Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-44-A4SS-01A-11R-A24X-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
tretinoin_homo sapiens_gpl6244_gds4180	GEO Signatures of Differentially Expressed Genes for Small Molecules	1.0	null
PE(22:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE112761,GSE112767_2_v_0_ddx6_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
TGIF1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	42.6286
BRD-K90887068	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.16888
PE(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
Sebum	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.818
Cervical squamous cell carcinoma and endocervical adenocarcinoma_CESC_TCGA-EA-A3QE-01A-21R-A21T-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Viscus	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
PE(20:4(8Z,11Z,14Z,17Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PMC12019518-ao5c02459_si_002.xlsx-Table_S3-Table_S3_Screening_of_genes_that_are_commonly_upregulated_in_cells_on_stiff_substrate_and_down-regulated_by_KD_of_UBE2A_B_AR	Rummagene Transcription Factor Associations 2026	1.0	null
PC(18:1(11Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K86155080	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.16051
Perturb_14503_KO_Tgfb3_SRP020224	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	-1.0	-5.2488
PC(22:2(13Z,16Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Bone disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.025
intermediate part of r9B	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.62519
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
GSE122215,GSE122217_0_v_2_peg10_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
intermediate stratum of r6Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.15832
ventrolateral prefrontal cortex_12 pcw_F_13060	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.27221
anterior (rostral) cingulate (medial prefrontal) cortex_30 yrs_F_12290	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-0.857835
PE(22:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
18332912-Table2	GeneSigDB Published Gene Signatures	1.0	null
Vermal regions	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.29952
primary motor cortex (area M1, area 4)_3 yrs_M_12980	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.65596
CRCGN012_HEPG2_24H:O06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.66127
Crus 2, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.44374
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-let-7d	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
hematopoietic system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.054313
PC(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K80630598	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.53094
mantle zone of r8BI	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.02366
PC(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN013_HEPG2_24H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.2257
LysoPC(20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
GSE199255,GSE199356_3_v_2_pds5a_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PC(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
primary somatosensory cortex (area S1, areas 3,1,2)_1 yrs_F_12830	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.55376
PC(P-18:1(11Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-BA-A6DG-01A-21R-A30B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-A97270959	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.53382
PE(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Posterolateral visual area	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.05666
PC(20:2(11Z,14Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Olig2	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	22.8185
PC(18:1(9Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Calcium	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K62248885	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.5658
Crus 1, molecular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.10119
POLR2A_MCF 10A_hg19_2	ENCODE Transcription Factor Binding Site Profiles	1.0	null
BRD-K00137579	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.38764
PE(24:1(15Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
intermediate stratum of r6BI	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.2606
PE(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-let-7g	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
BRD-K23162004	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.93632
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN016_MCF10A.WT.HP_24H:N15	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.10565
PC(dm18:1(11Z)/dm18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K43700313	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.73262
YMB-1-E	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.44227
CRCGN015_MCF10A_48H:O10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.44265
NH6	CCLE Cell Line Gene CNV Profiles	-1.0	-1.38578
PC(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
GSE155305_3_v_1_ifitm3_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PE(20:2(11Z,14Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
GSE65617_0_v_1_aire_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PE(20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-22:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
496100392_HIP_dementia_TBI_90-94_F	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	1.0	2.36962
PE(20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-484	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
PC(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:1(9Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K11310449	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.06512
PC(20:1(11Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
SNU245	CCLE Cell Line Gene Expression Profiles	1.0	1.53486
PC(20:3(5Z,8Z,11Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-665	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.55165
retropontine reticular area	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.18419
PE(22:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
MAX	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	29.4755
PC(22:4(7Z,10Z,13Z,16Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_HEPG2_48H:M08	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.54531
PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-FG-A4MY-01A-11R-A26U-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
Adrenocortical carcinoma_ACC_TCGA-OR-A5J3-01A-11R-A29S-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(16:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
calcium-dependent phospholipase A2 activity	GO Molecular Function Annotations 2025	1.0	null
CRCGN017_MCF10A.TP53.M_24H:H07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.6777
bone marrow	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.078007
PE(18:3(6Z,9Z,12Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
IMR32	CCLE Cell Line Gene CNV Profiles	-1.0	-2.1588
CRCGN010_HEPG2_24H:O01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.82
CRCGN012_HEPG2_24H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.8802
STAT3	ChEA Transcription Factor Targets	1.0	null
PE(15:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
muscular system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.068445
ZNF706	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.16376
PC(22:2(13Z,16Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
lateral parabrachial nucleus	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.1067
CRCGN014_HEPG2_24H:I11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.22602
CRCGN017_MCF10A.WT.HP_24H:K23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.7202
PE(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
ES-I3 Cells	Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles	1.0	1.5623
PE(16:1(9Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K39534157	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.22987
BLOC1S6	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	4.00519
Vascular disease	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	1.0	1.281
PE(22:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
cellular metabolic process	GO Biological Process Annotations 2015	1.0	null
GSE232631_4_v_1_brca2_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PC(24:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K40034229	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.43697
PE(22:4(7Z,10Z,13Z,16Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:1(11Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GNAI2	Hub Proteins Protein-Protein Interactions	1.0	null
hsa-miR-3155b	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
HS888T	CCLE Cell Line Gene Expression Profiles	-1.0	-1.51189
PE(16:1(9Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:2(13Z,16Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-P3-A6T7-01A-11R-A34R-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_3H:D07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.92267
BRD-K23701005	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.10658
Acyl chain remodelling of PC	Reactome Pathways 2014	1.0	null
MS-1	COSMIC Cell Line Gene Mutation Profiles	1.0	null
Culmen	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.47346
PE(18:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GSE164494_1_v_2_angiotensin ii_mouse	RummaGEO Drug Perturbation Signatures	-1.0	null
PC(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(15:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
Lobules IV-V, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.47896
Acyl chain remodelling of PS	Reactome Pathways 2014	1.0	null
CRCGN011_HEPG2_24H:O06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.9726
PBX-27287812-CHIP-SEQ-EMBYONIC-LIMB-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
bladder	GTEx Tissue Gene Expression Profiles	1.0	1.66858
CRCGN017_MCF10A.TP53.M_24H:L22	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.4151
GSE216043_11_v_2_cisplatin_human	RummaGEO Drug Perturbation Signatures	1.0	null
cellular biosynthetic process	GO Biological Process Annotations 2015	1.0	null
PE(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
GSE160817_0_v_8_slamf6_human	RummaGEO Gene Perturbation Signatures	1.0	null
CRCGN015_HEPG2_48H:E13	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.25869
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K07164317	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.25772
phospholipase a2 activity	GO Molecular Function Annotations 2015	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-S5-A6DX-01A-11R-A31N-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(18:1(9Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K04092807	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.69763
PC(24:1(15Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
CHAGO-K-1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.80454
Alpha-Linolenic acid	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(6Z,9Z,12Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Cystic Fibrosis	HuGE Navigator Gene-Phenotype Associations	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
abnormal testis morphology	MGI Mouse Phenotype Associations 2023	1.0	null
NRL	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	15.3316
PC(18:3(6Z,9Z,12Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
DMS 79	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.95283
endocrine gland	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.057148
GSE191015_1_v_3_gsdmb_human	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K73858940	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.14892
calcium ion binding	GO Molecular Function Annotations 2025	1.0	null
PC(P-16:0/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K33420995	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.13911
BRD-K70154746	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.78168
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(o-18:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(9Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
TCF12	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	29.5974
Perturb_2480_Mut_ESR1_SRP254635	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	-20.0
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
21205295-TableS1	GeneSigDB Published Gene Signatures	1.0	null
H3K4me1_megakaryocyte_mm9_3	ENCODE Histone Modification Site Profiles	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K06911479	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.34899
PE(14:1(9Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
hippocampus (hippocampal formation)_21 pcw_F_12365	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.67732
CRCGN010_HEPG2_24H:O06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.39839
colon	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.069556
CRCGN009_HEPG2_24H:O05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.82933
Perturb_8625_KO_Hnrnpd_SRP311571	PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations	1.0	20.0
iia	GeneRIF Biological Term Annotations	1.0	null
PE(22:2(13Z,16Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
r7 part of gigantocellular reticular area	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.48686
PC(18:1(9Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
ZEB1	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	28.1016
PC(14:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/P-18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K56488838	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.797
BRD-K62202988	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.49126
GSE148692,GSE148695_2_v_3_satb2_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
CRCGN014_HEPG2_24H:J18	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.7091
CRCGN017_MCF10A.TP53.M_24H:G11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.2344
RARA_KD_GDS4065_42_human_MCF-7	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
EKVX	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.914318
CRCGN008_HEPG2_24H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.5794
PC(16:1(9Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Stratum corneum	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	1.767
PMC11551338-pnas.2411189121.sd01.xlsx-PXR-Unnamed_0_NR1I2	Rummagene Transcription Factor Associations 2026	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
intermediate stratum of r9BL	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-2.05408
PE(15:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PMC3009535__F3	PFOCR Pathway Figure Associations 2024	1.0	null
POU5F1-16518401-CHIP-PET-MESCS-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
BRD-K25138450	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.15062
PC(20:4(8Z,11Z,14Z,17Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:1(11Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K25097691	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.10034
BRD-K88344082	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.80784
PC(16:1(9Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
EPHA4_drugactivation_229_GSE26523	GEO Signatures of Differentially Expressed Genes for Kinase Perturbations	-1.0	-1.37594
PE(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
GSE146687_2_v_5_eribulin_human	RummaGEO Drug Perturbation Signatures	1.0	null
carcinoma	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.052481
PE(18:4(6Z,9Z,12Z,15Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
Paraflocculus, granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.73818
Prdm4	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	22.4708
PE(22:4(7Z,10Z,13Z,16Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:0/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
SNU-475	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.44374
CRCGN016_MCF10A.WT.HP_24H:D04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.9554
KDM1A_KD_GDS5055_367_mouse_adipose tissue	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	null
PC(P-18:1(11Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K84391462	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.16883
PC(18:2(9Z,12Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K12347309	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.32571
Human - Tonsil - L2 - Outer surface	HuBMAP Azimuth Cell Type Annotations	1.0	null
PE(22:1(13Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K98086832	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.34447
BRD-K24743998	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.21254
white matter of cerebellar vermis	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.21745
POLR2A_H1-hESC_hg19_3	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PC(14:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K77519898	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.92074
PE(20:3(5Z,8Z,11Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:P23	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.60647
PC(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K69872823	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.10756
PE(18:3(9Z,12Z,15Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K03546460	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.38123
PE(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
VMRCLCD	DepMap CRISPR Gene Dependency	1.0	2.2813
H2AFZ_mammary epithelial cell_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PC(18:1(9Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(22:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K73942403	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	4.0706
Nr2f6	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	60.6827
reticular formation of p1Lim	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.2172
FOXA1_T47D_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
respiratory system	TISSUES Curated Tissue Protein Expression Evidence Scores	1.0	null
tacrolimus-284	CMAP Signatures of Differentially Expressed Genes for Small Molecules	-1.0	null
PC(18:2(9Z,12Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
KP-N-YS	COSMIC Cell Line Gene Mutation Profiles	1.0	null
Lung squamous cell carcinoma_LUSC_TCGA-66-2768-01A-01R-0851-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
EJM	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.56498
BRD-K41876347	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.92311
PE(20:0/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
Lung squamous cell carcinoma_LUSC_TCGA-77-8131-01A-11R-2247-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
NCI-H510A	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	2.0142
PC(24:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
H3K4me3_G1E-ER4_mm9_3	ENCODE Histone Modification Site Profiles	1.0	null
primary somatosensory cortex (area S1, areas 3,1,2)_21 yrs_F_13057	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	2.4419
SIHA	COSMIC Cell Line Gene Mutation Profiles	1.0	null
reproductive system	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.066665
PE(20:3(8Z,11Z,14Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
LS1034	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.18897
PE(20:1(11Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(o-16:0/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PMC12179083-Table_6.xlsx-VCF_Variants_Master_File-Gene_TBX1	Rummagene Transcription Factor Associations 2026	1.0	null
PC(18:3(9Z,12Z,15Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
cerebellar vermis	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.24619
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:4(7Z,10Z,13Z,16Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Head and Neck squamous cell carcinoma_HNSC_TCGA-BA-5558-01A-01R-1514-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K50713036	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.28385
PE(24:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:3(9Z,12Z,15Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
right colon	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.830291
SNU886	DepMap CRISPR Gene Dependency	1.0	7.74666
SNU16	CCLE Cell Line Gene Expression Profiles	1.0	1.49359
PC(o-16:1(9Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
cellular_component	LOCATE Predicted Protein Localization Annotations	1.0	null
H3K4me1_heart_mm9_2	ENCODE Histone Modification Site Profiles	1.0	null
Bhlha15	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	36.3504
TrigeminalGanglion	BioGPS Human Cell Type and Tissue Gene Expression Profiles	1.0	2.21192
NCIH292	CCLE Cell Line Gene CNV Profiles	-1.0	-1.73434
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
infection	GAD High Level Gene-Disease Associations	1.0	0.293278
Folium-tuber vermis (VII), granular layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.26127
Lung squamous cell carcinoma_LUSC_TCGA-85-A4QQ-01A-41R-A262-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(24:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
1-alkyl-2-acetylglycerophosphocholine esterase complex	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	1.238
PC(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K95359959	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-4.23805
GSE216043_7_v_0_cisplatin_human	RummaGEO Drug Perturbation Signatures	-1.0	null
CRCGN010_HEPG2_24H:C19	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.71402
PE(18:1(11Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(14:1(9Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
TP53-22573176-HFKS-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K66248685	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.27252
PC(16:1(9Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
AIRE	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	2.82072
PE(20:3(5Z,8Z,11Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K83935370	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.30826
phosphatidylcholine acyl-chain remodeling	GO Biological Process Annotations 2025	1.0	null
Brain - Hippocampus	GTEx Tissue Gene Expression Profiles 2023	1.0	4.71619
BRD-K48861177	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.68149
cellular_component	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.663342
PMC7755285__F11	PFOCR Pathway Figure Associations 2024	1.0	null
PE(22:1(13Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-504	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.809003
CRCGN008_HEPG2_24H:M04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.17545
PE(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-2861	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.965816
PE(24:0/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:1(15Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
PIN1_DEPLETION_GDS4070_450_human_MDA-MB-231 breast cancer cells	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
PC(22:1(13Z)/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-2277-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
NCIH2110	CCLE Cell Line Gene Expression Profiles	-1.0	-1.90751
phosphatidylglycerol metabolic process	GO Biological Process Annotations 2015	1.0	null
H3K27me3_K562_hg19_4	ENCODE Transcription Factor Binding Site Profiles	1.0	null
CHP126	CCLE Cell Line Gene CNV Profiles	-1.0	-1.93579
intracellular	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.237908
BRD-K69840402	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.05004
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
AdrenalCortex	BioGPS Human Cell Type and Tissue Gene Expression Profiles	1.0	1.36167
NOS-1	COSMIC Cell Line Gene CNV Profiles	1.0	3.12177
CRCGN008_HEPG2_24H:O06	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.81905
CRCGN011_HEPG2_24H:O04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.7706
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PMC12179083-Table_6.xlsx-VCF_Variants_Master_File-Gene_symbol_TBX1	Rummagene Transcription Factor Associations 2026	1.0	null
PE(20:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
membrane	LOCATE Curated Protein Localization Annotations	1.0	null
PE(18:2(9Z,12Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-107	TargetScan Predicted Conserved microRNA Targets	1.0	0.632343
PE(20:1(11Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
G-361	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.28916
PC(22:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
TFEC	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	19.4187
PC(16:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
ATM_KD_GSE54268_661_human_MCF-10A	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	-1.0	null
PC(20:4(5Z,8Z,11Z,14Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K66039243	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.30749
Nuclear outer membrane	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	1.0	0.71
orbital frontal cortex_30 yrs_F_12290	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	-1.0	-1.38487
PMC8033524-EMMM-13-e13162-s004.xlsx-d_GREAT_on_NFIB_bound-genes_HF-Unnamed_0_NFIB	Rummagene Transcription Factor Associations 2026	1.0	null
BRD-K79735667	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.20711
Acyl chain remodelling of PG	Reactome Pathways 2024	1.0	null
PC(20:3(5Z,8Z,11Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
Copula pyramidis	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.53246
PC(P-18:1(9Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
LysoPC(24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
Msgn1	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	19.9004
CRCGN011_HEPG2_24H:O03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.9964
BRD-K69350885	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.36102
PC(o-16:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:P07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.05092
phosphatidylethanolamine acyl-chain remodeling	GO Biological Process Annotations 2015	1.0	null
PC(18:0/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
glycerophospholipid metabolism	KEGG Pathways	1.0	null
CRCGN010_HEPG2_24H:D11	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.1779
PC(15:0/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
organ system cancer	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.039439
PC(24:1(15Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-4297	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.13535
POLR2A	ENCODE Transcription Factor Targets	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K88836117	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.33692
NCI-H28	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.4856
PC(o-22:0/22:3(10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PMC8046804-41467_2021_22478_MOESM11_ESM.xlsx-Del_AA-TCGA-Unnamed_6_TEAD1	Rummagene Transcription Factor Associations 2026	1.0	null
Glycerophospholipid biosynthesis	Reactome Pathways 2014	1.0	null
spla2	GeneRIF Biological Term Annotations	1.0	null
PC(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Mantle	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.891
PMC6930440-jcav11p0520s3.xlsx-MI_vs_FG-Unnamed_0_MITF	Rummagene Transcription Factor Associations 2026	1.0	null
PMC9794594-DataSheet_1.xlsx-ST12-Unnamed_1_KLF6	Rummagene Transcription Factor Associations 2026	1.0	null
PE(20:2(11Z,14Z)/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K82362034	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.26344
GSE175787_13_v_0_rhoc_human	RummaGEO Gene Perturbation Signatures	1.0	null
PC(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(9Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
SON_KD_GDS4448_35_human_HeLa	GEO Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	null
PC(18:1(9Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(11Z)/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PSN1	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-0.851817
PC(18:3(9Z,12Z,15Z)/18:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-3127-5p	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.0155
BRD-K82827604	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.32974
rt4	HPA Cell Line Gene Expression Profiles	1.0	0.947002
PC(14:1(9Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
GFI1B	ChEA Transcription Factor Targets	1.0	null
long term depression	KEGG Pathways	1.0	null
BRD-K52054012	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.07268
OVMIU	DepMap CRISPR Gene Dependency	1.0	3.82443
Tridecanoic acid	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
COR-L279	GDSC Cell Line Gene Expression Profiles	1.0	1.65163
DU4475	DepMap CRISPR Gene Dependency	1.0	2.46319
PU.1-20176806-MACROPHAGES-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PE(18:1(11Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
tissues, cell types and enzyme sources	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
AOC2	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.04487
POLR2AphosphoS5_G1E_mm9_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PMC10794186-41598_2024_51947_MOESM16_ESM.xlsx-Supplementary_Table_14_Shared-Supplementary_Table_14_Shared_genes_between_Gong_et_al_clusters_and_SOX9-AS1_regulated_genes_SOX9	Rummagene Transcription Factor Associations 2026	1.0	null
PE(16:0/22:1(13Z))	HMDB Metabolites of Enzymes	1.0	null
Synovial cell	TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025	1.0	0.76
BRD-K37634338	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.30854
H4K20me1_HeLa-S3_hg19_1	ENCODE Histone Modification Site Profiles	1.0	null
PE(18:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(14:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
H4	DepMap CRISPR Gene Dependency	1.0	2.74109
CRCGN015_MCF10A_48H:K10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.34532
cytoplasmic part	COMPARTMENTS Curated Protein Localization Evidence Scores	1.0	0.237908
EP300_K562_hg19_1	ENCODE Transcription Factor Binding Site Profiles	1.0	null
atopic dermatitis	DISEASES Text-mining Gene-Disease Association Evidence Scores	1.0	0.552075
lipid biosynthetic process	GO Biological Process Annotations 2015	1.0	null
BRD-K34541722	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.69102
Arachidonic acid	HMDB Metabolites of Enzymes	1.0	null
Prostate adenocarcinoma_PRAD_TCGA-YL-A8HL-01A-11R-A36G-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Ansiform lobule	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	2.24863
PC(P-18:1(11Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K39516553	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.15479
CRCGN010_HEPG2_24H:H07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.6832
Rfx6	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	19.4754
PC(22:1(13Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PE(24:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(24:1(15Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE201239_3_v_4_fmr1_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/16:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-18:1(11Z)/22:4(7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Linoleic acid metabolism	KEGG Pathways 2026	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
r3 part of cochlear sensory column	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.25714
OB olfactory fiber layer	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.00738
PC(24:0/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
Brain Lower Grade Glioma_LGG_TCGA-DU-7304-02A-12R-A36H-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(16:1(9Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K42716291	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.16783
PC(18:1(9Z)/15:0)	HMDB Metabolites of Enzymes	1.0	null
HL60	BioGPS Cell Line Gene Expression Profiles	1.0	1.89634
MDA-MB-415	GDSC Cell Line Gene Expression Profiles	1.0	1.71428
PE(20:3(5Z,8Z,11Z)/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE258991_5_v_0_enzalutamide_human	RummaGEO Drug Perturbation Signatures	1.0	null
cellular nitrogen compound metabolic process	GO Biological Process Annotations 2015	1.0	null
PE(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(20:4(5Z,8Z,11Z,14Z)/20:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K90702609	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.55758
PE(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PE(16:1(9Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-miR-596	TargetScan Predicted Conserved microRNA Targets	1.0	0.136254
PC(16:1(9Z)/18:4(6Z,9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
liminal part of the r6 alar plate	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.04132
Perturb_3837_KO_ING3_SRP304782	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	15.7336
Acute Myeloid Leukemia_LAML_TCGA-AB-2813-03A-01T-0736-13	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(20:3(8Z,11Z,14Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
hsa-let-7a	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.2992
Brain Lower Grade Glioma_LGG_TCGA-DU-6402-01A-11R-1708-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
primary visual cortex (striate cortex, area V1/17)_15 yrs_M_12299	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.58141
TTC642	DepMap CRISPR Gene Dependency	1.0	3.17548
CRCGN015_MCF10A.WT.HP_24H:C07	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	4.08211
PE(24:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN014_HEPG2_24H:F03	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.42995
PC(18:3(9Z,12Z,15Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
SRF	JASPAR Predicted Transcription Factor Targets	1.0	null
PE(18:3(9Z,12Z,15Z)/20:2(11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
CRCGN012_HEPG2_24H:C20	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.03724
BRD-K87658102	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.72635
PC(P-18:0/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
GSE145915_5_v_4_pcm1_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
alimentary canal	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.054324
GSE216147_2_v_1_rbm20_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
PE(O-18:1(1Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:2(9Z,12Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
CRCGN015_MCF10A.TP53.M_24H:G14	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.3038
PC(15:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:2(11Z,14Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K58971526	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.05574
PC(18:1(9Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
BRD-K96925976	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.63071
PE(18:0/14:0)	HMDB Metabolites of Enzymes	1.0	null
PE(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
BT-549	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	1.03698
phosphatidylcholine acyl-chain remodeling	GO Biological Process Annotations 2023	1.0	null
RIPPLY3	CM4AI KOLF21J CRISPRi Gene Perturbation Atlas	1.0	3.06532
BRD-K12524715	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.09358
PC(16:0/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
HCC2885	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.4856
Stearic acid	HMDB Metabolites of Enzymes	1.0	null
GSE229671,GSE229673_2_v_1_yrdc_human	RummaGEO Gene Perturbation Signatures	-1.0	null
carbohydrate derivative metabolic process	GO Biological Process Annotations 2015	1.0	null
CRCGN016_MCF10A.TP53.M_24H:F05	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.82577
PE(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K53354260	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.20608
PE(22:2(13Z,16Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/22:5(4Z,7Z,10Z,13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
GSE204811,GSE204813_1_v_3_trim29_human	RummaGEO Gene Perturbation Signatures	1.0	null
PE(18:2(9Z,12Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
r10 part of gigantocellular reticular area	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.27188
vas deferens	TISSUES Text-mining Tissue Protein Expression Evidence Scores	1.0	0.739678
PC(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
PC(P-16:0/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(o-16:0/18:0)	HMDB Metabolites of Enzymes	1.0	null
PE(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
MDA-MB-175-VII	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.85458
PE(22:5(7Z,10Z,13Z,16Z,19Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:0/P-18:0)	HMDB Metabolites of Enzymes	1.0	null
SUP-T1	COSMIC Cell Line Gene Mutation Profiles	1.0	null
enlarged heart	MGI Mouse Phenotype Associations 2023	1.0	null
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
POLR2AphosphoS5_G1E_mm9_2	ENCODE Transcription Factor Binding Site Profiles	1.0	null
PE(18:2(9Z,12Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
RUNX2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	30.3911
PC(P-18:1(11Z)/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
r6 part of basomedial reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.17332
m2 part of substantia nigra compacta	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.35869
PC(22:4(7Z,10Z,13Z,16Z)/18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:4(6Z,9Z,12Z,15Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PMC7755285__F11	PFOCR Pathway Figure Associations 2023	1.0	null
CRCGN015_HEPG2_48H:O12	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	5.30172
Lung adenocarcinoma_LUAD_TCGA-78-7540-01A-11R-2066-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
BRD-K05096562	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.40607
PE(18:3(6Z,9Z,12Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
PE(16:0/20:3(8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
Bach1::Mafk	JASPAR Predicted Mouse Transcription Factor Targets 2025	1.0	23.2281
cellular modified amino acid metabolic process	GO Biological Process Annotations 2015	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-ZF-A9RC-01A-11R-A38B-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PC(P-18:0/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K41707029	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.54988
CRCGN015_HEPG2_48H:G02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.07215
CRCGN015_HEPG2_48H:F16	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.71935
PC(P-18:1(11Z)/16:0)	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
59M	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	0.843299
intermediate stratum of r8BI	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.29383
SNAI2	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	25.4332
PE(15:0/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(4Z,7Z,10Z,13Z,16Z)/24:0)	HMDB Metabolites of Enzymes	1.0	null
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K23280067	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.5729
r6 part of basointermediate reticular formation	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	-1.0	-1.26142
PE(20:0/18:3(9Z,12Z,15Z))	HMDB Metabolites of Enzymes	1.0	null
Pentadecanoic acid	HMDB Metabolites of Enzymes	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-BT-A3PH-01A-11R-A220-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
Perturb_13687_KD_ATG5_ERP127841	PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations	1.0	7.27404
MOLT-16	COSMIC Cell Line Gene Mutation Profiles	1.0	null
PC(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
SCC-15	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	-1.0	-1.03978
BRD-K69074358	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.19507
H3K4me1_testis_mm9_1	ENCODE Histone Modification Site Profiles	1.0	null
PE(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))	HMDB Metabolites of Enzymes	1.0	null
19605494-TableS1	GeneSigDB Published Gene Signatures	1.0	null
MEWO	Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles	1.0	2.64342
PE(20:4(8Z,11Z,14Z,17Z)/20:1(11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(14:0/P-18:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
skin	HPA Tissue Gene Expression Profiles	1.0	1.39295
Brain Lower Grade Glioma_LGG_TCGA-FG-8189-01B-11R-A28M-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
hsa-miR-34a	TargetScan Predicted Nonconserved microRNA Targets	1.0	0.965816
snoutepidermis	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	1.0	2.09859
CRCGN012_HEPG2_24H:G02	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	3.67015
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))	HMDB Metabolites of Enzymes	1.0	null
PC(15:0/14:1(9Z))	HMDB Metabolites of Enzymes	1.0	null
GSE174406_2_v_0_lin28b_mouse	RummaGEO Gene Perturbation Signatures	-1.0	null
CRCGN014_HEPG2_3H:L18	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.39718
superficial stratum of r1BM	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.08213
LBP-1	MotifMap Predicted Transcription Factor Targets	1.0	null
BRD-K97624648	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.28399
H3K9ac_Peripheral Blood Mononuclear Primary Cells	Roadmap Epigenomics Histone Modification Site Profiles	1.0	null
PC(20:0/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
Lung adenocarcinoma_LUAD_TCGA-50-8459-01A-11R-2326-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
CRCGN015_HEPG2_48H:J10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	6.56905
CRCGN015_HEPG2_48H:P04	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	7.06857
PC(24:1(15Z)/18:2(9Z,12Z))	HMDB Metabolites of Enzymes	1.0	null
negative regulation of T cell activation	GO Biological Process Annotations 2023	1.0	null
mediodorsal nucleus of thalamus_4 mos_M_12296	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	1.0	1.09233
CRCGN014_HEPG2_3H:L01	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.02296
phosphatidylinositol metabolic process	GO Biological Process Annotations 2015	1.0	null
Major island of Calleja	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	1.0	1.0761
PC(18:3(6Z,9Z,12Z)/22:2(13Z,16Z))	HMDB Metabolites of Enzymes	1.0	null
Endocrine gland	TISSUES Curated Tissue Protein Expression Evidence Scores 2025	1.0	4.0
BRD-K87558616	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.22088
decreased body weight	MGI Mouse Phenotype Associations 2023	1.0	null
CRCGN016_MCF10A.TP53.M_24H:K10	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	1.0	2.32735
CSB-26484114-CHIP-SEQ-FIBROBLAST-HUMAN	ChEA Transcription Factor Targets 2022	1.0	null
PC(18:0/24:0)	HMDB Metabolites of Enzymes	1.0	null
Bladder Urothelial Carcinoma_BLCA_TCGA-CF-A7I0-01A-22R-A352-07	TCGA Signatures of Differentially Expressed Genes for Tumors	1.0	null
PE(18:2(9Z,12Z)/24:1(15Z))	HMDB Metabolites of Enzymes	1.0	null
GSE145915_3_v_2_pcm1_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
KPNSI9S	CCLE Cell Line Gene CNV Profiles	-1.0	-3.20986
PC(20:3(8Z,11Z,14Z)/22:0)	HMDB Metabolites of Enzymes	1.0	null
PC(16:1(9Z)/P-16:0)	HMDB Metabolites of Enzymes	1.0	null
GSE231799_3_v_4_nfkbie_mouse	RummaGEO Gene Perturbation Signatures	1.0	null
ESRRB	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	28.9468
JHOC5	CCLE Cell Line Gene CNV Profiles	1.0	1.37417
hsa-miR-4493	TargetScan Predicted Nonconserved microRNA Targets	1.0	1.13535
BRD-K57202089	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.15123
BRD-K86358396	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.14425
ZNF682	JASPAR Predicted Human Transcription Factor Targets 2025	1.0	63.9981
PU.1-20513432-MACROPHAGES-MOUSE	ChEA Transcription Factor Targets 2022	1.0	null
PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	HMDB Metabolites of Enzymes	1.0	null
PC(20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))	HMDB Metabolites of Enzymes	1.0	null
BRD-K58577862	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	1.0	3.7243
BRD-K38519585	LINCS L1000 CMAP Chemical Perturbation Consensus Signatures	-1.0	-3.00943
PC(20:4(5Z,8Z,11Z,14Z)/18:0)	HMDB Metabolites of Enzymes	1.0	null
